97 results on '"Hyperglycemia genetics"'
Search Results
2. Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice.
- Author
-
Chen YC, Taylor AJ, Fulcher JM, Swensen AC, Dai XQ, Komba M, Wrightson KLC, Fok K, Patterson AE, Klein Geltink RI, MacDonald PE, Qian WJ, and Verchere CB
- Subjects
- Animals, Mice, Glucose metabolism, Insulin metabolism, Mice, Knockout, Obesity metabolism, Proinsulin metabolism, Streptozocin, Carboxypeptidase H genetics, Carboxypeptidase H metabolism, Diabetes Mellitus, Type 2 metabolism, Hyperglycemia genetics, Hyperglycemia metabolism, Insulin-Secreting Cells metabolism, Islets of Langerhans metabolism
- Abstract
Carboxypeptidase E (CPE) facilitates the conversion of prohormones into mature hormones and is highly expressed in multiple neuroendocrine tissues. Carriers of CPE mutations have elevated plasma proinsulin and develop severe obesity and hyperglycemia. We aimed to determine whether loss of Cpe in pancreatic β-cells disrupts proinsulin processing and accelerates development of diabetes and obesity in mice. Pancreatic β-cell-specific Cpe knockout mice (βCpeKO; Cpefl/fl x Ins1Cre/+) lack mature insulin granules and have elevated proinsulin in plasma; however, glucose-and KCl-stimulated insulin secretion in βCpeKO islets remained intact. High-fat diet-fed βCpeKO mice showed weight gain and glucose tolerance comparable with those of Wt littermates. Notably, β-cell area was increased in chow-fed βCpeKO mice and β-cell replication was elevated in βCpeKO islets. Transcriptomic analysis of βCpeKO β-cells revealed elevated glycolysis and Hif1α-target gene expression. On high glucose challenge, β-cells from βCpeKO mice showed reduced mitochondrial membrane potential, increased reactive oxygen species, reduced MafA, and elevated Aldh1a3 transcript levels. Following multiple low-dose streptozotocin injections, βCpeKO mice had accelerated development of hyperglycemia with reduced β-cell insulin and Glut2 expression. These findings suggest that Cpe and proper proinsulin processing are critical in maintaining β-cell function during the development of hyperglycemia., Article Highlights: Carboxypeptidase E (Cpe) is an enzyme that removes the carboxy-terminal arginine and lysine residues from peptide precursors. Mutations in CPE lead to obesity and type 2 diabetes in humans, and whole-body Cpe knockout or mutant mice are obese and hyperglycemic and fail to convert proinsulin to insulin. We show that β-cell-specific Cpe deletion in mice (βCpeKO) does not lead to the development of obesity or hyperglycemia, even after prolonged high-fat diet treatment. However, β-cell proliferation rate and β-cell area are increased, and the development of hyperglycemia induced by multiple low-dose streptozotocin injections is accelerated in βCpeKO mice., (© 2023 by the American Diabetes Association.)
- Published
- 2023
- Full Text
- View/download PDF
3. TBK1-mTOR Signaling Attenuates Obesity-Linked Hyperglycemia and Insulin Resistance.
- Author
-
Bodur C, Kazyken D, Huang K, Tooley AS, Cho KW, Barnes TM, Lumeng CN, Myers MG, and Fingar DC
- Subjects
- Mice, Animals, Multiprotein Complexes metabolism, TOR Serine-Threonine Kinases metabolism, Mechanistic Target of Rapamycin Complex 1 metabolism, Mechanistic Target of Rapamycin Complex 2, Sirolimus pharmacology, Insulin metabolism, Obesity genetics, Mice, Obese, Glucose, Protein Serine-Threonine Kinases genetics, Insulin Resistance genetics, Hyperglycemia genetics
- Abstract
The innate immune kinase TBK1 (TANK-binding kinase 1) responds to microbial-derived signals to initiate responses against viral and bacterial pathogens. More recent work implicates TBK1 in metabolism and tumorigenesis. The kinase mTOR (mechanistic target of rapamycin) integrates diverse environmental cues to control fundamental cellular processes. Our prior work demonstrated in cells that TBK1 phosphorylates mTOR (on S2159) to increase mTORC1 and mTORC2 catalytic activity and signaling. Here we investigate a role for TBK1-mTOR signaling in control of glucose metabolism in vivo. We find that mice with diet-induced obesity (DIO) but not lean mice bearing a whole-body "TBK1-resistant" Mtor S2159A knock-in allele (MtorA/A) display exacerbated hyperglycemia and systemic insulin resistance with no change in energy balance. Mechanistically, Mtor S2159A knock-in in DIO mice reduces mTORC1 and mTORC2 signaling in response to insulin and innate immune agonists, reduces anti-inflammatory gene expression in adipose tissue, and blunts anti-inflammatory macrophage M2 polarization, phenotypes shared by mice with tissue-specific inactivation of TBK1 or mTOR complexes. Tissues from DIO mice display elevated TBK1 activity and mTOR S2159 phosphorylation relative to lean mice. We propose a model whereby obesity-associated signals increase TBK1 activity and mTOR phosphorylation, which boost mTORC1 and mTORC2 signaling in parallel to the insulin pathway, thereby attenuating insulin resistance to improve glycemic control during diet-induced obesity., (© 2022 by the American Diabetes Association.)
- Published
- 2022
- Full Text
- View/download PDF
4. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
- Author
-
Zhao S, Lo CS, Miyata KN, Ghosh A, Zhao XP, Chenier I, Cailhier JF, Ethier J, Lattouf JB, Filep JG, Ingelfinger JR, Zhang SL, and Chan JSD
- Subjects
- Animals, Cells, Cultured, Diabetes Mellitus, Experimental complications, Diabetes Mellitus, Experimental genetics, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Experimental pathology, Diabetic Nephropathies genetics, Diabetic Nephropathies metabolism, Disease Progression, Female, Humans, Hyperglycemia genetics, Hyperglycemia metabolism, Kidney Tubules, Proximal metabolism, Kidney Tubules, Proximal pathology, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Sodium-Glucose Transporter 2 metabolism, Up-Regulation genetics, Diabetic Nephropathies pathology, Hyperglycemia pathology, NF-E2-Related Factor 2 genetics, Sodium-Glucose Transporter 2 genetics
- Abstract
We investigated the impact of nuclear factor erythroid 2-related factor 2 (Nrf2) overexpression in renal proximal tubular cells (RPTCs) on blood glucose, kidney injury, and sodium-glucose cotransporter 2 (Sglt2) expression in diabetic Akita Nrf2
-/- / Nrf2RPTC promoter and human kidneys from patients with diabetes were also studied. Nrf2 overexpression was associated with increased blood glucose, glomerular filtration rate, urinary albumin-to-creatinine ratio, tubulointerstitial fibrosis, and Sglt2 expression in Akita SGLT2 promoter and human kidneys from patients with diabetes were also studied. Nrf2 overexpression was associated with increased blood glucose, glomerular filtration rate, urinary albumin-to-creatinine ratio, tubulointerstitial fibrosis, and Sglt2 expression in Akita Nrf2-/- / Nrf2RPTC Tg mice compared with their Akita Nrf2-/- littermates. In vitro, oltipraz or transfection of NRF2 cDNA stimulated SGLT2 expression and SGLT2 promoter activity in HK2, and these effects were inhibited by trigonelline or NRF2 siRNA. The deletion of the NRF2 -responsive element ( NRF2-RE ) in the SGLT2 promoter was confirmed by gel mobility shift assay and chromatin immunoprecipitation assays. Kidneys from patients with diabetes exhibited higher levels of NRF2 and SGLT2 in the RPTCs than kidneys from patients without diabetes. These results suggest a link by which NRF2 mediates hyperglycemia stimulation of SGLT2 expression and exacerbates blood glucose and kidney injury in diabetes.SGLT2 promoter activity. NRF2 binding to the NRF2-RE of the SGLT2 promoter was confirmed by gel mobility shift assay and chromatin immunoprecipitation assays. Kidneys from patients with diabetes exhibited higher levels of NRF2 and SGLT2 in the RPTCs than kidneys from patients without diabetes. These results suggest a link by which NRF2 mediates hyperglycemia stimulation of SGLT2 expression and exacerbates blood glucose and kidney injury in diabetes., (© 2021 by the American Diabetes Association.)- Published
- 2021
- Full Text
- View/download PDF
5. CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy.
- Author
-
Chen J, Fleming T, Katz S, Dewenter M, Hofmann K, Saadatmand A, Kronlage M, Werner MP, Pokrandt B, Schreiter F, Lin J, Katz D, Morgenstern J, Elwakiel A, Sinn P, Gröne HJ, Hammes HP, Nawroth PP, Isermann B, Sticht C, Brügger B, Katus HA, Hagenmueller M, and Backs J
- Subjects
- Animals, Calcium-Calmodulin-Dependent Protein Kinase Type 2 genetics, Diabetes Mellitus, Type 2 genetics, Diabetic Nephropathies genetics, Diabetic Retinopathy genetics, Gene Expression, Hyperglycemia genetics, Mice, Mice, Knockout, Receptors, Leptin genetics, Receptors, Leptin metabolism, Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism, Diabetes Mellitus, Type 2 metabolism, Diabetic Nephropathies metabolism, Diabetic Retinopathy metabolism, Hyperglycemia metabolism
- Abstract
Type 2 diabetes has become a pandemic and leads to late diabetic complications of organs, including kidney and eye. Lowering hyperglycemia is the typical therapeutic goal in clinical medicine. However, hyperglycemia may only be a symptom of diabetes but not the sole cause of late diabetic complications; instead, other diabetes-related alterations could be causative. Here, we studied the role of CaM kinase II-δ (CaMKIIδ), which is known to be activated through diabetic metabolism. CaMKIIδ is expressed ubiquitously and might therefore affect several different organ systems. We crossed diabetic leptin receptor-mutant mice to mice lacking CaMKIIδ globally. Remarkably, CaMKIIδ-deficient diabetic mice did not develop hyperglycemia. As potential underlying mechanisms, we provide evidence for improved insulin sensing with increased glucose transport into skeletal muscle and also reduced hepatic glucose production. Despite normoglycemia, CaMKIIδ-deficient diabetic mice developed the full picture of diabetic nephropathy, but diabetic retinopathy was prevented. We also unmasked a retina-specific gene expression signature that might contribute to CaMKII-dependent retinal diabetic complications. These data challenge the clinical concept of normalizing hyperglycemia in diabetes as a causative treatment strategy for late diabetic complications and call for a more detailed analysis of intracellular metabolic signals in different diabetic organs., (© 2020 by the American Diabetes Association.)
- Published
- 2021
- Full Text
- View/download PDF
6. Angiogenic Factor AGGF1-Primed Endothelial Progenitor Cells Repair Vascular Defect in Diabetic Mice.
- Author
-
Yao Y, Li Y, Song Q, Hu C, Xie W, Xu C, Chen Q, and Wang QK
- Subjects
- Angiogenic Proteins genetics, Animals, Cell- and Tissue-Based Therapy, Cells, Cultured, Diet, High-Fat, HEK293 Cells, Haploinsufficiency genetics, Haploinsufficiency physiology, Humans, Hyperglycemia genetics, Hyperglycemia physiopathology, Lentivirus genetics, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Platelet Endothelial Cell Adhesion Molecule-1 genetics, Platelet Endothelial Cell Adhesion Molecule-1 metabolism, Angiogenic Proteins metabolism, Bone Marrow Cells metabolism, Muscle, Skeletal metabolism
- Abstract
Hyperglycemia-triggered vascular abnormalities are the most serious complications of diabetes mellitus (DM). The major cause of vascular dysfunction in DM is endothelial injury and dysfunction associated with the reduced number and dysfunction of endothelial progenitor cells (EPCs). A major challenge is to identify key regulators of EPCs to restore DM-associated vascular dysfunction. We show that EPCs from heterozygous knockout Aggf1
+/- mice presented with impairment of proliferation, migration, angiogenesis, and transendothelial migration as in hyperglycemic mice fed a high-fat diet (HFD) or db/db mice. The number of EPCs from Aggf1+/- mice was significantly reduced. Ex vivo, AGGF1 protein can fully reverse all damaging effects of hyperglycemia on EPCs. In vivo, transplantation of AGGF1-primed EPCs successfully restores blood flow and blocks tissue necrosis and ambulatory impairment in HFD-induced hyperglycemic mice or db/db mice with diabetic hindlimb ischemia. Mechanistically, AGGF1 activates AKT, reduces nuclear localization of Fyn, which increases the nuclear level of Nrf2 and expression of antioxidative genes, and inhibits reactive oxygen species generation. These results suggest that Aggf1 is required for essential function of EPCs, AGGF1 fully reverses the damaging effects of hyperglycemia on EPCs, and AGGF1 priming of EPCs is a novel treatment modality for vascular complications in DM., (© 2019 by the American Diabetes Association.)- Published
- 2019
- Full Text
- View/download PDF
7. Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization.
- Author
-
Chen X, Zhuo S, Zhu T, Yao P, Yang M, Mei H, Li N, Ma F, Wang JM, Chen S, Ye RD, Li Y, and Le Y
- Subjects
- Animals, Body Temperature genetics, Energy Metabolism genetics, Fatty Liver genetics, Fatty Liver immunology, Hyperglycemia genetics, Hyperglycemia immunology, Hyperlipidemias genetics, Hyperlipidemias immunology, Inflammation genetics, Inflammation immunology, Insulin Resistance immunology, Mice, Mice, Knockout, Mice, Obese, Serum Amyloid A Protein metabolism, Thermogenesis genetics, Chemotaxis genetics, Diet, High-Fat, Insulin Resistance genetics, Macrophages immunology, Receptors, Formyl Peptide genetics
- Abstract
Obesity and related inflammation are critical for the pathogenesis of insulin resistance, but the underlying mechanisms are not fully understood. Formyl peptide receptor 2 (FPR2) plays important roles in host immune responses and inflammation-related diseases. We found that Fpr2 expression was elevated in the white adipose tissue of high-fat diet (HFD)-induced obese mice and db/db mice. The systemic deletion of Fpr2 alleviated HFD-induced obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis. Furthermore, Fpr2 deletion in HFD-fed mice elevated body temperature, reduced fat mass, and inhibited inflammation by reducing macrophage infiltration and M1 polarization in metabolic tissues. Bone marrow transplantations between wild-type and Fpr2
-/- mice and myeloid-specific Fpr2 deletion demonstrated that Fpr2-expressing myeloid cells exacerbated HFD-induced obesity, insulin resistance, glucose/lipid metabolic disturbances, and inflammation. Mechanistic studies revealed that Fpr2 deletion in HFD-fed mice enhanced energy expenditure probably through increasing thermogenesis in skeletal muscle; serum amyloid A3 and other factors secreted by adipocytes induced macrophage chemotaxis via Fpr2; and Fpr2 deletion suppressed macrophage chemotaxis and lipopolysaccharide-, palmitate-, and interferon-γ-induced macrophage M1 polarization through blocking their signals. Altogether, our studies demonstrate that myeloid Fpr2 plays critical roles in obesity and related metabolic disorders via regulating muscle energy expenditure, macrophage chemotaxis, and M1 polarization., (© 2019 by the American Diabetes Association.)- Published
- 2019
- Full Text
- View/download PDF
8. Senescent T Cells Predict the Development of Hyperglycemia in Humans.
- Author
-
Lee YH, Kim SR, Han DH, Yu HT, Han YD, Kim JH, Kim SH, Lee CJ, Min BH, Kim DH, Kim KH, Cho JW, Lee WW, Shin EC, and Park S
- Subjects
- CD57 Antigens metabolism, CD8 Antigens metabolism, Cellular Senescence genetics, Humans, Hyperglycemia genetics, Immunohistochemistry, Immunophenotyping, Leukocytes, Mononuclear metabolism, Logistic Models, Longitudinal Studies, Prospective Studies, Cellular Senescence physiology, Hyperglycemia metabolism, T-Lymphocytes cytology, T-Lymphocytes metabolism
- Abstract
Senescent T cells have been implicated in chronic inflammatory and cardiovascular diseases. In this study, we explored the relationship between senescent T cells and glycemic status in a cohort of 805 participants by investigating the frequency of CD57
+ or CD28null senescent T cells in peripheral blood. Participants with normal glucose tolerance (NGT) with follow-up data ( N = 149) were included to determine whether hyperglycemia (prediabetes or type 2 diabetes) developed during follow-up (mean 2.3 years). CD8+ CD57+ and CD8+ CD28null T-cell frequencies were significantly higher in prediabetes and type 2 diabetes compared with NGT. Increased CD57+ or CD28null cells in the CD8+ T-cell subset were independently associated with hyperglycemia. Furthermore, among participants with baseline NGT, the frequency of CD8+ CD57+ T cells was an independent predictor of hyperglycemia development. Immunofluorescent analyses confirmed that CD8+ CD57+ T-cell infiltration was increased in visceral adipose tissue of patients with prediabetes or type 2 diabetes compared with those with NGT. Our data suggest that increased frequency of senescent CD8+ T cells in the peripheral blood is associated with development of hyperglycemia., (© 2018 by the American Diabetes Association.)- Published
- 2019
- Full Text
- View/download PDF
9. Insights From Molecular Characterization of Adult Patients of Families With Multigenerational Diabetes.
- Author
-
Pezzilli S, Ludovico O, Biagini T, Mercuri L, Alberico F, Lauricella E, Dallali H, Capocefalo D, Carella M, Miccinilli E, Piscitelli P, Scarale MG, Mazza T, Trischitta V, and Prudente S
- Subjects
- Adult, Aged, Basic Helix-Loop-Helix Transcription Factors genetics, Female, Germinal Center Kinases, Hepatocyte Nuclear Factor 1-alpha genetics, Hepatocyte Nuclear Factor 1-beta genetics, Hepatocyte Nuclear Factor 4 genetics, Homeodomain Proteins genetics, Humans, Hyperglycemia genetics, Male, Middle Aged, Mutation genetics, Pedigree, Protein Serine-Threonine Kinases genetics, Trans-Activators genetics, Diabetes Mellitus, Type 2 genetics, High-Throughput Nucleotide Sequencing methods
- Abstract
Multigenerational diabetes of adulthood is a mostly overlooked entity, simplistically lumped into the large pool of type 2 diabetes. The general aim of our research in the past few years is to unravel the genetic causes of this form of diabetes. Identifying among families with multigenerational diabetes those who carry mutations in known monogenic diabetes genes is the first step to then allow us to concentrate on remaining pedigrees in which to unravel new diabetes genes. Targeted next-generation sequencing of 27 monogenic diabetes genes was carried out in 55 family probands and identified mutations verified among their relatives by Sanger sequencing. Nine variants (in eight probands) survived our filtering/prioritization strategy. After likelihood of causality assessment by established guidelines, six variants were classified as "pathogenetic/likely pathogenetic" and two as "of uncertain significance." Combining present results with our previous data on the six genes causing the most common forms of maturity-onset diabetes of the young allows us to infer that 23.6% of families with multigenerational diabetes of adulthood carry mutations in known monogenic diabetes genes. Our findings indicate that the genetic background of hyperglycemia is unrecognized in the vast majority of families with multigenerational diabetes of adulthood. These families now become the object of further research aimed at unraveling new diabetes genes., (© 2017 by the American Diabetes Association.)
- Published
- 2018
- Full Text
- View/download PDF
10. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
- Author
-
Tong X, Zhang D, Charney N, Jin E, VanDommelen K, Stamper K, Gupta N, Saldate J, and Yin L
- Subjects
- Animals, Blotting, Western, Cell Line, Cryptochromes genetics, DNA-Binding Proteins genetics, Diet, High-Fat adverse effects, Forkhead Box Protein O1 genetics, Gluconeogenesis genetics, Glucose metabolism, Humans, Hyperglycemia etiology, Hyperglycemia genetics, Immunoprecipitation, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Ubiquitination genetics, Ubiquitination physiology, Cryptochromes metabolism, DNA-Binding Proteins metabolism, Forkhead Box Protein O1 metabolism, Gluconeogenesis physiology, Hyperglycemia metabolism, Liver metabolism
- Abstract
Targeted protein degradation through ubiquitination is an important step in the regulation of glucose metabolism. Here, we present evidence that the DDB1-CUL4A ubiquitin E3 ligase functions as a novel metabolic regulator that promotes FOXO1-driven hepatic gluconeogenesis. In vivo, hepatocyte-specific Ddb1 deletion leads to impaired hepatic gluconeogenesis in the mouse liver but protects mice from high-fat diet-induced hyperglycemia. Lack of Ddb1 downregulates FOXO1 protein expression and impairs FOXO1-driven gluconeogenic response. Mechanistically, we discovered that DDB1 enhances FOXO1 protein stability via degrading the circadian protein cryptochrome 1 (CRY1), a known target of DDB1 E3 ligase. In the Cry1 depletion condition, insulin fails to reduce the nuclear FOXO1 abundance and suppress gluconeogenic gene expression. Chronic depletion of Cry1 in the mouse liver not only increases FOXO1 protein but also enhances hepatic gluconeogenesis. Thus, we have identified the DDB1-mediated CRY1 degradation as an important target of insulin action on glucose homeostasis., (© 2017 by the American Diabetes Association.)
- Published
- 2017
- Full Text
- View/download PDF
11. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
- Author
-
Yang W, Wang J, Chen Z, Chen J, Meng Y, Chen L, Chang Y, Geng B, Sun L, Dou L, Li J, Guan Y, Cui Q, and Yang J
- Subjects
- Adenosine Triphosphate metabolism, Adult, Animals, Case-Control Studies, Cytokines genetics, Cytokines metabolism, Female, Gene Knock-In Techniques, Gene Knockdown Techniques, Glucose Tolerance Test, HEK293 Cells, Hep G2 Cells, Humans, Hyperglycemia metabolism, Lipolysis, Male, Mice, Middle Aged, NF-E2 Transcription Factor, p45 Subunit metabolism, Non-alcoholic Fatty Liver Disease metabolism, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Gluconeogenesis genetics, Hepatocytes metabolism, Hyperglycemia genetics, Liver metabolism, MicroRNAs genetics, NF-E2 Transcription Factor, p45 Subunit genetics, Non-alcoholic Fatty Liver Disease genetics
- Abstract
Hepatic FAM3A expression is repressed under obese conditions, but the underlying mechanism remains unknown. This study determined the role and mechanism of miR-423-5p in hepatic glucose and lipid metabolism by repressing FAM3A expression. miR-423-5p expression was increased in the livers of obese diabetic mice and in patients with nonalcoholic fatty liver disease (NAFLD) with decreased FAM3A expression. miR-423-5p directly targeted FAM3A mRNA to repress its expression and the FAM3A-ATP-Akt pathway in cultured hepatocytes. Hepatic miR-423-5p inhibition suppressed gluconeogenesis and improved insulin resistance, hyperglycemia, and fatty liver in obese diabetic mice. In contrast, hepatic miR-423-5p overexpression promoted gluconeogenesis and hyperglycemia and increased lipid deposition in normal mice. miR-423-5p inhibition activated the FAM3A-ATP-Akt pathway and repressed gluconeogenic and lipogenic gene expression in diabetic mouse livers. The miR-423 precursor gene was further shown to be a target gene of NFE2, which induced miR-423-5p expression to repress the FAM3A-ATP-Akt pathway in cultured hepatocytes. Hepatic NFE2 overexpression upregulated miR-423-5p to repress the FAM3A-ATP-Akt pathway, promoting gluconeogenesis and lipid deposition and causing hyperglycemia in normal mice. In conclusion, under the obese condition, activation of the hepatic NFE2/miR-423-5p axis plays important roles in the progression of type 2 diabetes and NAFLD by repressing the FAM3A-ATP-Akt signaling pathway., (© 2017 by the American Diabetes Association.)
- Published
- 2017
- Full Text
- View/download PDF
12. A Whole-Genome RNA Interference Screen Reveals a Role for Spry2 in Insulin Transcription and the Unfolded Protein Response.
- Author
-
Pappalardo Z, Gambhir Chopra D, Hennings TG, Richards H, Choe J, Yang K, Baeyens L, Ang K, Chen S, Arkin M, German MS, McManus MT, and Ku GM
- Subjects
- Animals, Annexin A5 metabolism, Blotting, Western, Calcium metabolism, Cell Line, Diabetes Mellitus, Type 2 metabolism, Endoplasmic Reticulum metabolism, Gene Knockdown Techniques, Genome-Wide Association Study, Humans, Hyperglycemia genetics, Hyperglycemia metabolism, Insulin metabolism, Mice, Protein Serine-Threonine Kinases, RNA Interference, Real-Time Polymerase Chain Reaction, Sarcoplasmic Reticulum Calcium-Transporting ATPases metabolism, eIF-2 Kinase metabolism, Diabetes Mellitus, Type 2 genetics, Gene Expression Regulation genetics, Insulin genetics, Insulin-Secreting Cells metabolism, Intracellular Signaling Peptides and Proteins genetics, Membrane Proteins genetics, Unfolded Protein Response genetics
- Abstract
Insulin production by the pancreatic β-cell is required for normal glucose homeostasis. While key transcription factors that bind to the insulin promoter are known, relatively little is known about the upstream regulators of insulin transcription. Using a whole-genome RNA interference screen, we uncovered 26 novel regulators of insulin transcription that regulate diverse processes including oxidative phosphorylation, vesicle traffic, and the unfolded protein response (UPR). We focused on Spry2 -a gene implicated in human type 2 diabetes by genome-wide association studies but without a clear connection to glucose homeostasis. We showed that Spry2 is a novel UPR target and its upregulation is dependent on PERK. Knockdown of Spry2 resulted in reduced expression of Serca2, reduced endoplasmic reticulum calcium levels, and induction of the UPR. Spry2 deletion in the adult mouse β-cell caused hyperglycemia and hypoinsulinemia. Our study greatly expands the compendium of insulin promoter regulators and demonstrates a novel β-cell link between Spry2 and human diabetes., (© 2017 by the American Diabetes Association.)
- Published
- 2017
- Full Text
- View/download PDF
13. MICU1 Alleviates Diabetic Cardiomyopathy Through Mitochondrial Ca 2+ -Dependent Antioxidant Response.
- Author
-
Ji L, Liu F, Jing Z, Huang Q, Zhao Y, Cao H, Li J, Yin C, Xing J, and Li F
- Subjects
- Animals, Blotting, Western, Cells, Cultured, Diabetic Cardiomyopathies diagnostic imaging, Diabetic Cardiomyopathies metabolism, Echocardiography, Gene Knockdown Techniques, Glutathione metabolism, Glutathione Disulfide metabolism, Hyperglycemia genetics, Immunohistochemistry, Mice, NAD metabolism, NADP metabolism, Rats, Reactive Oxygen Species metabolism, Real-Time Polymerase Chain Reaction, Apoptosis genetics, Calcium metabolism, Calcium-Binding Proteins genetics, Diabetic Cardiomyopathies genetics, Mitochondria, Heart metabolism, Mitochondrial Membrane Transport Proteins genetics, Myocytes, Cardiac metabolism
- Abstract
Diabetic cardiomyopathy is a major cause of mortality in patients with diabetes, but specific strategies for preventing or treating diabetic cardiomyopathy have not been clarified yet. MICU1 is a key regulator of mitochondrial Ca
2+ uptake, which plays important roles in regulating mitochondrial oxidative phosphorylation and redox balance. To date, however, the significance of MICU1 in diabetic hearts has not been investigated. Here, we demonstrate that MICU1 was downregulated in db/db mouse hearts, which contributes to myocardial apoptosis in diabetes. Importantly, the reconstitution of MICU1 in diabetic hearts significantly inhibited the development of diabetic cardiomyopathy, as evidenced by enhanced cardiac function and reduced cardiac hypertrophy and myocardial fibrosis in db/db mice. Moreover, our in vitro data show that the reconstitution of MICU1 inhibited the apoptosis of cardiomyocytes, induced by high glucose and high fat, through increasing mitochondrial Ca2+ uptake and subsequently activating the antioxidant system. Finally, our results indicate that hyperglycemia and hyperlipidemia induced the downregulation of MICU1 by inhibiting Sp1 expression in diabetic cardiomyocytes. Collectively, our findings provide the first direct evidence that upregulated MICU1 preserves cardiac function in diabetic db/db mice, suggesting that increasing the expression or activity of MICU1 may be a pharmacological approach to ameliorate cardiomyopathy in diabetes., (© 2017 by the American Diabetes Association.)- Published
- 2017
- Full Text
- View/download PDF
14. Hyperglycemia-Induced Changes in ZIP7 and ZnT7 Expression Cause Zn 2+ Release From the Sarco(endo)plasmic Reticulum and Mediate ER Stress in the Heart.
- Author
-
Tuncay E, Bitirim VC, Durak A, Carrat GRJ, Taylor KM, Rutter GA, and Turan B
- Subjects
- Animals, Blotting, Western, Casein Kinase II genetics, Cation Transport Proteins metabolism, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Type 1 metabolism, Heart Ventricles cytology, Hyperglycemia genetics, Hyperglycemia metabolism, Immunoprecipitation, Phosphorylation, RNA, Messenger metabolism, Rats, Rats, Wistar, Reverse Transcriptase Polymerase Chain Reaction, Zinc metabolism, Cation Transport Proteins genetics, Diabetes Mellitus, Experimental genetics, Diabetes Mellitus, Type 1 genetics, Endoplasmic Reticulum metabolism, Endoplasmic Reticulum Stress genetics, Myocytes, Cardiac metabolism, Sarcoplasmic Reticulum metabolism
- Abstract
Changes in cellular free Zn
2+ concentration, including those in the sarco(endo)plasmic reticulum [S(E)R], are primarily coordinated by Zn2+ transporters (ZnTs) whose identity and role in the heart are not well established. We hypothesized that ZIP7 and ZnT7 transport Zn2+ in opposing directions across the S(E)R membrane in cardiomyocytes and that changes in their activity play an important role in the development of ER stress during hyperglycemia. The subcellular S(E)R localization of ZIP7 and ZnT7 was determined in cardiomyocytes and in isolated S(E)R preparations. Markedly increased mRNA and protein levels of ZIP7 were observed in ventricular cardiomyocytes from diabetic rats or high-glucose-treated H9c2 cells while ZnT7 expression was low. In addition, we observed increased ZIP7 phosphorylation in response to high glucose in vivo and in vitro. By using recombinant-targeted Förster resonance energy transfer sensors, we show that hyperglycemia induces a marked redistribution of cellular free Zn2+ , increasing cytosolic free Zn2+ and lowering free Zn2+ in the S(E)R. These changes involve alterations in ZIP7 phosphorylation and were suppressed by small interfering RNA-mediated silencing of CK2α. Opposing changes in the expression of ZIP7 and ZnT7 were also observed in hyperglycemia. We conclude that subcellular free Zn2+ redistribution in the hyperglycemic heart, resulting from altered ZIP7 and ZnT7 activity, contributes to cardiac dysfunction in diabetes., (© 2017 by the American Diabetes Association.)- Published
- 2017
- Full Text
- View/download PDF
15. Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.
- Author
-
Jourdan T, Szanda G, Cinar R, Godlewski G, Holovac DJ, Park JK, Nicoloro S, Shen Y, Liu J, Rosenberg AZ, Liu Z, Czech MP, and Kunos G
- Subjects
- Animals, Chemokine CCL2 metabolism, Diabetic Nephropathies metabolism, Gene Knockout Techniques, Hyperglycemia metabolism, Interferon Regulatory Factors metabolism, Interleukin-1beta, Male, Rats, Rats, Zucker, Receptor, Cannabinoid, CB1 metabolism, Signal Transduction, Tumor Necrosis Factor-alpha metabolism, Diabetes Mellitus, Type 2 metabolism, Diabetic Nephropathies genetics, Hyperglycemia genetics, Insulin-Secreting Cells metabolism, Islets of Langerhans metabolism, Macrophages metabolism, Receptor, Cannabinoid, CB1 genetics
- Abstract
Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CB
1 R)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CB1 R signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CB1 R are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CB1 R-/- bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CB1 R, interleukin-1β, tumor necrosis factor-α, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CB1 R activation increased Irf5 expression, whereas knockdown of Irf5 blunted CB1 R-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKα dependent. Macrophage-specific in vivo knockdown of Irf5 protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CB1 R signaling in macrophages and a potential therapeutic target., (© 2017 by the American Diabetes Association.)- Published
- 2017
- Full Text
- View/download PDF
16. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
- Author
-
Lizotte F, Denhez B, Guay A, Gévry N, Côté AM, and Geraldes P
- Subjects
- Animals, Cell Line, Diabetes Mellitus, Experimental metabolism, Diabetic Nephropathies genetics, Diabetic Nephropathies metabolism, Glomerular Filtration Rate physiology, Hyperglycemia genetics, Hyperglycemia metabolism, Immunohistochemistry, Insulin Resistance genetics, Insulin Resistance physiology, Kidney Glomerulus metabolism, Male, Mice, Mice, Inbred C57BL, Microscopy, Electron, Transmission, Promoter Regions, Genetic genetics, Receptor, Insulin genetics, Receptor, Insulin metabolism, Signal Transduction genetics, Signal Transduction physiology, Diabetes Mellitus, Experimental genetics, Epigenesis, Genetic genetics, Podocytes metabolism, Protein Tyrosine Phosphatase, Non-Receptor Type 6 genetics
- Abstract
Poor glycemic control profoundly affects protein expression and the cell signaling action that contributes to glycemic memory and irreversible progression of diabetic nephropathy (DN). We demonstrate that SHP-1 is elevated in podocytes of diabetic mice, causing insulin unresponsiveness and DN. Thus, sustained SHP-1 expression caused by hyperglycemia despite systemic glucose normalization could contribute to the glycemic memory effect in DN. Microalbuminuria, glomerular filtration rate, mesangial cell expansion, and collagen type IV and transforming growth factor-β expression were significantly increased in diabetic Ins2
+/C96Y mice compared with nondiabetic Ins2+/+ mice and remained elevated despite glucose normalization with insulin implants. A persistent increase of SHP-1 expression in podocytes despite normalization of systemic glucose levels was associated with sustained inhibition of the insulin signaling pathways. In cultured podocytes, high glucose levels increased mRNA, protein expression, and phosphatase activity of SHP-1, which remained elevated despite glucose concentration returning to normal, causing persistent insulin receptor-β inhibition. Histone posttranslational modification analysis showed that the promoter region of SHP-1 was enriched with H3K4me1 and H3K9/14ac in diabetic glomeruli and podocytes, which remained elevated despite glucose level normalization. Hyperglycemia induces SHP-1 promoter epigenetic modifications, causing its persistent expression and activity and leading to insulin resistance, podocyte dysfunction, and DN., (© 2016 by the American Diabetes Association.)- Published
- 2016
- Full Text
- View/download PDF
17. Zinc-Associated Variant in SLC30A8 Gene Interacts With Gestational Weight Gain on Postpartum Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes Mellitus.
- Author
-
Wang T, Liu H, Wang L, Huang T, Li W, Zheng Y, Heianza Y, Sun D, Leng J, Zhang S, Li N, Hu G, and Qi L
- Subjects
- Adult, Blood Glucose metabolism, Cation Transport Proteins metabolism, Diabetes, Gestational blood, Diabetes, Gestational metabolism, Female, Genotype, Gestational Age, Glucose Tolerance Test, Glycated Hemoglobin metabolism, Humans, Hyperglycemia blood, Hyperglycemia genetics, Hyperglycemia metabolism, Longitudinal Studies, Postpartum Period blood, Postpartum Period genetics, Postpartum Period metabolism, Pregnancy, Retrospective Studies, Risk Factors, Zinc blood, Zinc Transporter 8, Cation Transport Proteins genetics, Diabetes, Gestational genetics, Weight Gain genetics, Zinc metabolism
- Abstract
Zinc transporter 8 genetic variant SLC30A8 has been associated with postpartum risk of type 2 diabetes among women with gestational diabetes mellitus (GDM). Gestational weight gain is one of the strongest risk factors for postpartum hyperglycemia. We assessed the interaction between type 2 diabetes-associated SLC30A8 rs13266634 and gestational weight gain on 1-5 years of postpartum glycemic changes in 1,071 women with prior GDM in a longitudinal study. Compared with gestation of 26-30 weeks, postpartum levels of fasting glucose, oral glucose tolerance test 2-h glucose, and hemoglobin A
1c (HbA1c ) increased across rs13266634 TT, CT, and CC genotypes in women with excessive gestational weight gain, whereas opposite genetic associations were found in women with inadequate or adequate gestational weight gain. Postpartum changes in fasting glucose per additional copy of the C allele were -0.18, -0.04, and 0.12 mmol/L in women with inadequate, adequate, and excessive gestational weight gain, respectively (P for interaction = 0.002). We also found similar interactions for changes in 2-h glucose and HbA1c (P for interaction = 0.003 and 0.005, respectively). Our data indicate that gestational weight gain may modify SLC30A8 variant on long-term glycemic changes, highlighting the importance of gestational weight control in the prevention of postpartum hyperglycemia in women with GDM., (© 2016 by the American Diabetes Association.)- Published
- 2016
- Full Text
- View/download PDF
18. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.
- Author
-
Soares MA, Cohen OD, Low YC, Sartor RA, Ellison T, Anil U, Anzai L, Chang JB, Saadeh PB, Rabbani PS, and Ceradini DJ
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Animals, Blotting, Western, Cytoskeletal Proteins genetics, Diabetes Mellitus genetics, Fluorescent Antibody Technique, Glutathione, Hyperglycemia genetics, Immunoprecipitation, Kelch-Like ECH-Associated Protein 1, Mice, Mice, Inbred C57BL, Mice, Inbred Strains, NF-E2-Related Factor 2 genetics, NIH 3T3 Cells, Oxidative Stress genetics, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Skin injuries, Adaptor Proteins, Signal Transducing metabolism, Cytoskeletal Proteins metabolism, Diabetes Mellitus metabolism, Hyperglycemia metabolism, NF-E2-Related Factor 2 metabolism, Reactive Oxygen Species metabolism, Regeneration physiology, Skin metabolism, Wound Healing physiology, Wounds and Injuries metabolism
- Abstract
Chronic hyperglycemia impairs intracellular redox homeostasis and contributes to impaired diabetic tissue regeneration. The Keap1/Nrf2 pathway is a critical regulator of the endogenous antioxidant response system, and its dysfunction has been implicated in numerous pathologies. Here we characterize the effect of chronic hyperglycemia on Nrf2 signaling within a diabetic cutaneous regeneration model. We characterized the effects of chronic hyperglycemia on the Keap1/Nrf2 pathway within models of diabetic cutaneous wound regeneration. We assessed reactive oxygen species (ROS) production and antioxidant gene expression following alterations in the Nrf2 suppressor Keap1 and the subsequent changes in Nrf2 signaling. We also developed a topical small interfering RNA (siRNA)-based therapy to restore redox homeostasis within diabetic wounds. Western blotting demonstrated that chronic hyperglycemia-associated oxidative stress inhibits nuclear translocation of Nrf2 and impairs activation of antioxidant genes, thus contributing to ROS accumulation. Keap1 inhibition increased Nrf2 nuclear translocation, increased antioxidant gene expression, and reduced ROS production to normoglycemic levels, both in vitro and in vivo. Topical siKeap1 therapy resulted in improved regenerative capacity of diabetic wounds and accelerated closure. We report that chronic hyperglycemia weakens the endogenous antioxidant response, and the consequences of this defect are manifested by intracellular redox dysregulation, which can be restored by Keap1 inhibition. Targeted siRNA-based therapy represents a novel, efficacious strategy to reestablish redox homeostasis and accelerate diabetic cutaneous tissue regeneration., (© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2016
- Full Text
- View/download PDF
19. Lack of Prox1 Downregulation Disrupts the Expansion and Maturation of Postnatal Murine β-Cells.
- Author
-
Paul L, Walker EM, Drosos Y, Cyphert HA, Neale G, Stein R, South J, Grosveld G, Herrera PL, and Sosa-Pineda B
- Subjects
- Animals, Animals, Newborn, Cell Line, Chromatin Immunoprecipitation, Computer Simulation, Down-Regulation, Enzyme-Linked Immunosorbent Assay, Gene Expression Profiling, Gene Knockdown Techniques, Glucose Tolerance Test, Humans, Insulin-Secreting Cells cytology, Maf Transcription Factors, Large metabolism, Mice, Mice, Transgenic, Real-Time Polymerase Chain Reaction, Cell Differentiation genetics, Cell Proliferation genetics, Homeodomain Proteins genetics, Hyperglycemia genetics, Insulin metabolism, Insulin-Secreting Cells metabolism, Maf Transcription Factors, Large genetics, RNA, Messenger metabolism, Tumor Suppressor Proteins genetics
- Abstract
Transcription factor expression fluctuates during β-cell ontogeny, and disruptions in this pattern can affect the development or function of those cells. Here we uncovered that murine endocrine pancreatic progenitors express high levels of the homeodomain transcription factor Prox1, whereas both immature and mature β-cells scarcely express this protein. We also investigated if sustained Prox1 expression is incompatible with β-cell development or maintenance using transgenic mouse approaches. We discovered that Prox1 upregulation in mature β-cells has no functional consequences; in contrast, Prox1 overexpression in immature β-cells promotes acute fasting hyperglycemia. Using a combination of immunostaining and quantitative and comparative gene expression analyses, we determined that Prox1 upregulation reduces proliferation, impairs maturation, and enables apoptosis in postnatal β-cells. Also, we uncovered substantial deficiency in β-cells that overexpress Prox1 of the key regulator of β-cell maturation MafA, several MafA downstream targets required for glucose-stimulated insulin secretion, and genes encoding important components of FGF signaling. Moreover, knocking down PROX1 in human EndoC-βH1 β-cells caused increased expression of many of these same gene products. These and other results in our study indicate that reducing the expression of Prox1 is beneficial for the expansion and maturation of postnatal β-cells., (© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2016
- Full Text
- View/download PDF
20. MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction.
- Author
-
Ruiz M, Coderre L, Lachance D, Houde V, Martel C, Thompson Legault J, Gillis MA, Bouchard B, Daneault C, Carpentier AC, Gaestel M, Allen BG, and Des Rosiers C
- Subjects
- Animals, Carnitine analogs & derivatives, Carnitine metabolism, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental metabolism, Diabetic Cardiomyopathies metabolism, Fatty Acids, Nonesterified metabolism, Hyperglycemia genetics, Insulin blood, Insulin Resistance genetics, Ketone Bodies metabolism, Mice, Muscle Contraction genetics, Streptozocin, Triglycerides metabolism, Diabetes Mellitus, Experimental genetics, Diabetic Cardiomyopathies genetics, Gene Deletion, Intracellular Signaling Peptides and Proteins genetics, Lipid Metabolism genetics, Protein Serine-Threonine Kinases genetics
- Abstract
Heart disease remains a major complication of diabetes, and the identification of new therapeutic targets is essential. This study investigates the role of the protein kinase MK2, a p38 mitogen-activated protein kinase downstream target, in the development of diabetes-induced cardiomyopathy. Diabetes was induced in control (MK2(+/+)) and MK2-null (MK2(-/-)) mice using repeated injections of a low dose of streptozotocin (STZ). This protocol generated in MK2(+/+) mice a model of diabetes characterized by a 50% decrease in plasma insulin, hyperglycemia, and insulin resistance (IR), as well as major contractile dysfunction, which was associated with alterations in proteins involved in calcium handling. While MK2(-/-)-STZ mice remained hyperglycemic, they showed improved IR and none of the cardiac functional or molecular alterations. Further analyses highlighted marked lipid perturbations in MK2(+/+)-STZ mice, which encompass increased 1) circulating levels of free fatty acid, ketone bodies, and long-chain acylcarnitines and 2) cardiac triglyceride accumulation and ex vivo palmitate β-oxidation. MK2(-/-)-STZ mice were also protected against all these diabetes-induced lipid alterations. Our results demonstrate the benefits of MK2 deletion on diabetes-induced cardiac molecular and lipid metabolic changes, as well as contractile dysfunction. As a result, MK2 represents a new potential therapeutic target to prevent diabetes-induced cardiac dysfunction., (© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2016
- Full Text
- View/download PDF
21. Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone.
- Author
-
Oropeza D, Jouvet N, Budry L, Campbell JE, Bouyakdan K, Lacombe J, Perron G, Bergeron V, Neuman JC, Brar HK, Fenske RJ, Meunier C, Sczelecki S, Kimple ME, Drucker DJ, Screaton RA, Poitout V, Ferron M, Alquier T, and Estall JL
- Subjects
- Animals, Blood Glucose metabolism, Diabetes Mellitus, Experimental genetics, Homeostasis physiology, Human Growth Hormone genetics, Humans, Hyperglycemia genetics, Insulin blood, Male, Mice, Mice, Transgenic, Diabetes Mellitus, Experimental metabolism, Human Growth Hormone metabolism, Hyperglycemia metabolism, Insulin-Secreting Cells metabolism, Phenotype
- Abstract
There is growing concern over confounding artifacts associated with β-cell-specific Cre-recombinase transgenic models, raising questions about their general usefulness in research. The inducible β-cell-specific transgenic (MIP-CreERT(1Lphi)) mouse was designed to circumvent many of these issues, and we investigated whether this tool effectively addressed concerns of ectopic expression and disruption of glucose metabolism. Recombinase activity was absent from the central nervous system using a reporter line and high-resolution microscopy. Despite increased pancreatic insulin content, MIP-CreERT mice on a chow diet exhibited normal ambient glycemia, glucose tolerance and insulin sensitivity, and appropriate insulin secretion in response to glucose in vivo and in vitro. However, MIP-CreERT mice on different genetic backgrounds were protected from high-fat/ streptozotocin (STZ)-induced hyperglycemia that was accompanied by increased insulin content and islet density. Ectopic human growth hormone (hGH) was highly expressed in MIP-CreERT islets independent of tamoxifen administration. Circulating insulin levels remained similar to wild-type controls, whereas STZ-associated increases in α-cell number and serum glucagon were significantly blunted in MIP-CreERT(1Lphi) mice, possibly due to paracrine effects of hGH-induced serotonin expression. These studies reveal important new insight into the strengths and limitations of the MIP-CreERT mouse line for β-cell research., (© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2015
- Full Text
- View/download PDF
22. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
- Author
-
Amrutkar M, Cansby E, Chursa U, Nuñez-Durán E, Chanclón B, Ståhlman M, Fridén V, Mannerås-Holm L, Wickman A, Smith U, Bäckhed F, Borén J, Howell BW, and Mahlapuu M
- Subjects
- Acetyl-CoA Carboxylase metabolism, Animals, Blood Glucose metabolism, Body Composition genetics, Body Weight genetics, Diabetes Mellitus, Type 2 etiology, Diabetes Mellitus, Type 2 genetics, Fatty Liver genetics, Fatty Liver metabolism, Glucose Tolerance Test, Hyperglycemia genetics, Hyperglycemia metabolism, Hyperinsulinism genetics, Hyperinsulinism metabolism, Insulin metabolism, Intracellular Signaling Peptides and Proteins metabolism, Lipid Metabolism genetics, Liver metabolism, Male, Mice, Mice, Knockout, Protein Serine-Threonine Kinases metabolism, Diabetes Mellitus, Type 2 metabolism, Diet, High-Fat, Gluconeogenesis genetics, Insulin Resistance genetics, Intracellular Signaling Peptides and Proteins genetics, Protein Serine-Threonine Kinases genetics
- Abstract
Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new pharmacological approaches to treat type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a negative regulator of glucose and insulin homeostasis based on observations in myoblasts with acute depletion of STK25 and in STK25-overexpressing transgenic mice. Here, we challenged Stk25 knockout mice and wild-type littermates with a high-fat diet and showed that STK25 deficiency suppressed development of hyperglycemia and hyperinsulinemia, improved systemic glucose tolerance, reduced hepatic gluconeogenesis, and increased insulin sensitivity. Stk25(-/-) mice were protected from diet-induced liver steatosis accompanied by decreased protein levels of acetyl-CoA carboxylase, a key regulator of both lipid oxidation and synthesis. Lipid accumulation in Stk25(-/-) skeletal muscle was reduced, and expression of enzymes controlling the muscle oxidative capacity (Cpt1, Acox1, Cs, Cycs, Ucp3) and glucose metabolism (Glut1, Glut4, Hk2) was increased. These data are consistent with our previous study of STK25 knockdown in myoblasts and reciprocal to the metabolic phenotype of Stk25 transgenic mice, reinforcing the validity of the results. The findings suggest that STK25 deficiency protects against the metabolic consequences of chronic exposure to dietary lipids and highlight the potential of STK25 antagonists for the treatment of type 2 diabetes., (© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2015
- Full Text
- View/download PDF
23. Postnatal β-cell proliferation and mass expansion is dependent on the transcription factor Nkx6.1.
- Author
-
Taylor BL, Benthuysen J, and Sander M
- Subjects
- Animals, Cell Proliferation genetics, Cell Proliferation physiology, Homeodomain Proteins genetics, Hyperglycemia genetics, Hyperglycemia metabolism, Mice, Mice, Knockout, Homeodomain Proteins metabolism, Insulin-Secreting Cells metabolism
- Abstract
All forms of diabetes are characterized by a loss of functional β-cell mass, and strategies for expanding β-cell mass could have significant therapeutic benefit. We have recently identified the transcription factor Nkx6.1 as an essential maintenance factor of the functional β-cell state. In addition, Nkx6.1 has been proposed to control β-cell proliferation, but a role for Nkx6.1 in regulating β-cell mass has not been demonstrated. Here, we show that Nkx6.1 is required for postnatal β-cell mass expansion. Genetic inactivation of Nkx6.1 in newly formed β-cells caused a drastic decrease in early postnatal β-cell proliferation, leading to reduced β-cell mass and glucose intolerance. Interestingly, Nkx6.1 was dispensable for prenatal β-cell proliferation. We found that Nkx6.1 regulates the expression of several β-cell maturation markers as well as expression of the nutrient sensors Glut2 and Glp1r. Manifestation of the β-cell mass defect at the transition to postnatal feeding suggests that Nkx6.1 could regulate β-cell growth by enabling β-cells to respond to nutrient-dependent proliferation signals, such as glucose and Glp1. Identification of β-cell-intrinsic regulators that connect nutrient-sensing and proliferation suggests new therapeutic targets for expanding functional β-cell mass., (© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2015
- Full Text
- View/download PDF
24. Foxo1 inhibits diabetic mucosal wound healing but enhances healing of normoglycemic wounds.
- Author
-
Xu F, Othman B, Lim J, Batres A, Ponugoti B, Zhang C, Yi L, Liu J, Tian C, Hameedaldeen A, Alsadun S, Tarapore R, and Graves DT
- Subjects
- Animals, Blood Glucose metabolism, Cell Movement physiology, Cell Proliferation physiology, Chemokine CCL20 metabolism, Epithelial Cells cytology, Epithelial Cells physiology, Forkhead Box Protein O1, Forkhead Transcription Factors metabolism, Hyperglycemia genetics, Hyperglycemia pathology, Hyperglycemia physiopathology, Interleukin-1 metabolism, Keratinocytes cytology, Keratinocytes physiology, Mice, Knockout, Mouth Mucosa pathology, Neutrophils pathology, Neutrophils physiology, Primary Cell Culture, Transforming Growth Factor beta1 metabolism, Diabetes Mellitus, Experimental genetics, Diabetes Mellitus, Experimental pathology, Diabetes Mellitus, Experimental physiopathology, Forkhead Transcription Factors genetics, Mouth Mucosa physiopathology, Wound Healing physiology
- Abstract
Re-epithelialization is an important part in mucosal wound healing. Surprisingly little is known about the impact of diabetes on the molecular events of mucosal healing. We examined the role of the transcription factor forkhead box O1 (Foxo1) in oral wounds of diabetic and normoglycemic mice with keratinocyte-specific Foxo1 deletion. Diabetic mucosal wounds had significantly delayed healing with reduced cell migration and proliferation. Foxo1 deletion rescued the negative impact of diabetes on healing but had the opposite effect in normoglycemic mice. Diabetes in vivo and in high glucose conditions in vitro enhanced expression of chemokine (C-C motif) ligand 20 (CCL20) and interleukin-36γ (IL-36γ) in a Foxo1-dependent manner. High glucose-stimulated Foxo1 binding to CCL20 and IL-36γ promoters and CCL20 and IL-36γ significantly inhibited migration of these cells in high glucose conditions. In normal healing, Foxo1 was needed for transforming growth factor-β1 (TGF-β1) expression, and in standard glucose conditions, TGF-β1 rescued the negative effect of Foxo1 silencing on migration in vitro. We propose that Foxo1 under diabetic or high glucose conditions impairs healing by promoting high levels of CCL20 and IL-36γ expression but under normal conditions, enhances it by inducing TGF-β1. This finding provides mechanistic insight into how Foxo1 mediates the impact of diabetes on mucosal wound healing., (© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2015
- Full Text
- View/download PDF
25. PTEN deletion in pancreatic α-cells protects against high-fat diet-induced hyperglucagonemia and insulin resistance.
- Author
-
Wang L, Luk CT, Cai EP, Schroer SA, Allister EM, Shi SY, Wheeler MB, Gaisano HY, and Woo M
- Subjects
- Animals, Arginine metabolism, Diabetes Mellitus, Type 2 genetics, Diet, High-Fat, Female, Glucagon metabolism, Glucagon-Secreting Cells cytology, Glucagon-Secreting Cells metabolism, Hyperglycemia genetics, Hyperglycemia metabolism, Insulin-Secreting Cells cytology, Insulin-Secreting Cells physiology, Male, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Transgenic, PTEN Phosphohydrolase metabolism, Phosphatidylinositol 3-Kinases metabolism, RNA, Small Interfering genetics, Signal Transduction physiology, Diabetes Mellitus, Type 2 metabolism, Glucagon blood, Glucagon-Secreting Cells physiology, Insulin Resistance physiology, PTEN Phosphohydrolase genetics
- Abstract
An aberrant increase in circulating catabolic hormone glucagon contributes to type 2 diabetes pathogenesis. However, mechanisms regulating glucagon secretion and α-cell mass are not well understood. In this study, we aimed to demonstrate that phosphatidylinositol 3-kinase (PI3K) signaling is an important regulator of α-cell function. Mice with deletion of PTEN, a negative regulator of this pathway, in α-cells show reduced circulating glucagon levels and attenuated l-arginine-stimulated glucagon secretion both in vivo and in vitro. This hypoglucagonemic state is maintained after high-fat-diet feeding, leading to reduced expression of hepatic glycogenolytic and gluconeogenic genes. These beneficial effects protected high-fat diet-fed mice against hyperglycemia and insulin resistance. The data demonstrate an inhibitory role of PI3K signaling on α-cell function and provide experimental evidence for enhancing α-cell PI3K signaling for diabetes treatment., (© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2015
- Full Text
- View/download PDF
26. Increased DNA methyltransferase 3b (Dnmt3b)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy.
- Author
-
Wei D and Loeken MR
- Subjects
- Animals, DNA (Cytosine-5-)-Methyltransferases metabolism, DNA Methylation, Female, Gene Expression, Hyperglycemia metabolism, Mice, Mice, Inbred ICR, Neural Crest embryology, Neural Crest metabolism, Neural Tube embryology, Neural Tube metabolism, PAX3 Transcription Factor, Paired Box Transcription Factors metabolism, Pregnancy, DNA Methyltransferase 3B, CpG Islands physiology, DNA (Cytosine-5-)-Methyltransferases genetics, Hyperglycemia genetics, Oxidative Stress physiology, Paired Box Transcription Factors genetics
- Abstract
Previous studies have shown that diabetic embryopathy results from impaired expression of genes that are required for formation of embryonic structures. We have focused on Pax3, a gene that is expressed in embryonic neuroepithelium and is required for neural tube closure. Pax3 expression is inhibited in embryos of diabetic mice due to hyperglycemia-induced oxidative stress. DNA methylation silences developmentally expressed genes before differentiation. We hypothesized that hypomethylation of Pax3 upon neuroepithelial differentiation may be inhibited by hyperglycemia-induced oxidative stress. We tested this using embryos of pregnant hyperglycemic mice and mouse embryonic stem cells (ESC). Methylation of a Pax3 CpG island decreased upon neurulation of embryos and formation of neuronal precursors from ESC. In ESC, this was inhibited by oxidative stress. Use of short hairpin RNA in ESC demonstrated that DNA methyltransferase 3b (Dnmt3b) was responsible for methylation and silencing of Pax3 before differentiation and by oxidative stress. Although expression of Dnmt3b was not affected by oxidative stress, DNA methyltransferase activity was increased. These results indicate that hyperglycemia-induced oxidative stress stimulates Dnmt3b activity, thereby inhibiting chromatin modifications necessary for induction of Pax3 expression during neurulation and thus providing a molecular mechanism for defects caused by Pax3 insufficiency in diabetic pregnancy., (© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2014
- Full Text
- View/download PDF
27. Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.
- Author
-
Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, and Lauro D
- Subjects
- Animals, Blood Glucose metabolism, Diabetes Mellitus, Type 2 metabolism, Female, Glucose Tolerance Test, Hyperglycemia metabolism, Insulin metabolism, Insulin Resistance physiology, Mice, Knockout, Peroxiredoxin VI metabolism, Diabetes Mellitus, Type 2 genetics, Glucose metabolism, Hyperglycemia genetics, Islets of Langerhans metabolism, Oxidative Stress physiology, Peroxiredoxin VI genetics
- Abstract
Enhanced oxidative stress contributes to the pathogenesis of diabetes and its complications. Peroxiredoxin 6 (PRDX6) is a key regulator of cellular redox balance, with the peculiar ability to neutralize peroxides, peroxynitrite, and phospholipid hydroperoxides. In the current study, we aimed to define the role of PRDX6 in the pathophysiology of type 2 diabetes (T2D) using PRDX6 knockout (-/-) mice. Glucose and insulin responses were evaluated respectively by intraperitoneal glucose and insulin tolerance tests. Peripheral insulin sensitivity was analyzed by euglycemic-hyperinsulinemic clamp, and molecular tools were used to investigate insulin signaling. Moreover, inflammatory and lipid parameters were evaluated. We demonstrated that PRDX6(-/-) mice developed a phenotype similar to early-stage T2D caused by both reduced glucose-dependent insulin secretion and increased insulin resistance. Impaired insulin signaling was present in PRDX6(-/-) mice, leading to reduction of muscle glucose uptake. Morphological and ultrastructural changes were observed in islets of Langerhans and livers of mutant animals, as well as altered plasma lipid profiles and inflammatory parameters. In conclusion, we demonstrated that PRDX6 is a key mediator of overt hyperglycemia in T2D glucose metabolism, opening new perspectives for targeted therapeutic strategies in diabetes care., (© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.)
- Published
- 2014
- Full Text
- View/download PDF
28. Decreasing cx36 gap junction coupling compensates for overactive KATP channels to restore insulin secretion and prevent hyperglycemia in a mouse model of neonatal diabetes.
- Author
-
Nguyen LM, Pozzoli M, Hraha TH, and Benninger RK
- Subjects
- Animals, Animals, Newborn, Blood Glucose metabolism, Calcium metabolism, Connexins genetics, Diabetes Mellitus genetics, Homeostasis physiology, Hyperglycemia genetics, Insulin Secretion, Islets of Langerhans metabolism, KATP Channels genetics, Mice, Mice, Knockout, Mice, Transgenic, Gap Junction delta-2 Protein, Connexins metabolism, Diabetes Mellitus metabolism, Hyperglycemia metabolism, Insulin metabolism, KATP Channels metabolism
- Abstract
Mutations to the ATP-sensitive K(+) channel (KATP channel) that reduce the sensitivity of ATP inhibition cause neonatal diabetes mellitus via suppression of β-cell glucose-stimulated free calcium activity ([Ca(2+)]i) and insulin secretion. Connexin-36 (Cx36) gap junctions also regulate islet electrical activity; upon knockout of Cx36, β-cells show [Ca(2+)]i elevations at basal glucose. We hypothesized that in the presence of overactive ATP-insensitive KATP channels, a reduction in Cx36 would allow elevations in glucose-stimulated [Ca(2+)]i and insulin secretion to improve glucose homeostasis. To test this, we introduced a genetic knockout of Cx36 into mice that express ATP-insensitive KATP channels and measured glucose homeostasis and islet metabolic, electrical, and insulin secretion responses. In the normal presence of Cx36, after expression of ATP-insensitive KATP channels, blood glucose levels rapidly rose to >500 mg/dL. Islets from these mice showed reduced glucose-stimulated [Ca(2+)]i and no insulin secretion. In mice lacking Cx36 after expression of ATP-insensitive KATP channels, normal glucose levels were maintained. Islets from these mice had near-normal glucose-stimulated [Ca(2+)]i and insulin secretion. We therefore demonstrate a novel mechanism by which islet function can be recovered in a monogenic model of diabetes. A reduction of gap junction coupling allows sufficient glucose-stimulated [Ca(2+)]i and insulin secretion to prevent the emergence of diabetes.
- Published
- 2014
- Full Text
- View/download PDF
29. IG20/MADD plays a critical role in glucose-induced insulin secretion.
- Author
-
Li LC, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV, Wang Q, and Prabhakar BS
- Subjects
- Animals, Apoptosis physiology, Death Domain Receptor Signaling Adaptor Proteins genetics, Diabetes Mellitus, Type 2 genetics, Glucose Tolerance Test, Guanine Nucleotide Exchange Factors genetics, Hyperglycemia genetics, Insulin Resistance physiology, Insulin Secretion, Insulin-Secreting Cells metabolism, Mice, Mice, Knockout, Death Domain Receptor Signaling Adaptor Proteins metabolism, Diabetes Mellitus, Type 2 metabolism, Glucose metabolism, Guanine Nucleotide Exchange Factors metabolism, Hyperglycemia metabolism, Insulin metabolism
- Abstract
Pancreatic β-cell dysfunction is a common feature of type 2 diabetes. Earlier, we had cloned IG20 cDNA from a human insulinoma and had shown that IG20/MADD can encode six different splice isoforms that are differentially expressed and have unique functions, but its role in β-cell function was unexplored. To investigate the role of IG20/MADD in β-cell function, we generated conditional knockout (KMA1ko) mice. Deletion of IG20/MADD in β-cells resulted in hyperglycemia and glucose intolerance associated with reduced and delayed glucose-induced insulin production. KMA1ko β-cells were able to process insulin normally but had increased insulin accumulation and showed a severe defect in glucose-induced insulin release. These findings indicated that IG20/MADD plays a critical role in glucose-induced insulin release from β-cells and that its functional disruption can cause type 2 diabetes. The clinical relevance of these findings is highlighted by recent reports of very strong association of the rs7944584 single nucleotide polymorphism (SNP) of IG20/MADD with fasting hyperglycemia/diabetes. Thus, IG20/MADD could be a therapeutic target for type 2 diabetes, particularly in those with the rs7944584 SNP.
- Published
- 2014
- Full Text
- View/download PDF
30. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
- Author
-
Omar BA, Andersen B, Hald J, Raun K, Nishimura E, and Ahrén B
- Subjects
- Animals, Blood Glucose metabolism, Diabetes Mellitus, Experimental genetics, Glucagon-Like Peptide-1 Receptor, Glucagon-Secreting Cells metabolism, Glucose Tolerance Test, Hyperglycemia genetics, Insulin-Secreting Cells metabolism, Liver metabolism, Mice, Mice, Knockout, Pancreas metabolism, Peptide Fragments pharmacology, Receptors, Glucagon antagonists & inhibitors, Receptors, Glucagon genetics, Diabetes Mellitus, Experimental metabolism, Fibroblast Growth Factors metabolism, Glucagon-Like Peptide 1 metabolism, Hyperglycemia metabolism, Receptors, Glucagon metabolism
- Abstract
Mice genetically deficient in the glucagon receptor (Gcgr(-/-)) show improved glucose tolerance, insulin sensitivity, and α-cell hyperplasia. In addition, Gcgr(-/-) mice do not develop diabetes after chemical destruction of β-cells. Since fibroblast growth factor 21 (FGF21) has insulin-independent glucose-lowering properties, we investigated whether FGF21 was contributing to diabetes resistance in insulin-deficient Gcgr(-/-) mice. Plasma FGF21 was 25-fold higher in Gcgr(-/-) mice than in wild-type mice. FGF21 was found to be expressed in pancreatic β- and α-cells, with high expression in the hyperplastic α-cells of Gcgr(-/-) mice. FGF21 expression was also significantly increased in liver and adipose tissue of Gcgr(-/-) mice. To investigate the potential antidiabetic actions of FGF21 in insulin-deficient Gcgr(-/-) mice, an FGF21-neutralizing antibody was administered prior to oral glucose tolerance tests (OGTTs). FGF21 neutralization caused a decline in glucose tolerance in insulin-deficient Gcgr(-/-) mice during the OGTT. Despite this decline, insulin-deficient Gcgr(-/-) mice did not develop hyperglycemia. Glucagon-like peptide 1 (GLP-1) also has insulin-independent glucose-lowering properties, and an elevated circulating level of GLP-1 is a known characteristic of Gcgr(-/-) mice. Neutralization of FGF21, while concurrently blocking the GLP-1 receptor with the antagonist Exendin 9-39 (Ex9-39), resulted in significant hyperglycemia in insulin-deficient Gcgr(-/-) mice, while blocking with Ex9-39 alone did not. In conclusion, FGF21 acts additively with GLP-1 to prevent insulinopenic diabetes in mice lacking glucagon action.
- Published
- 2014
- Full Text
- View/download PDF
31. Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.
- Author
-
Giacco F, Du X, D'Agati VD, Milne R, Sui G, Geoffrion M, and Brownlee M
- Subjects
- Albuminuria genetics, Albuminuria metabolism, Albuminuria physiopathology, Animals, Blood Glucose metabolism, Diabetes Mellitus, Experimental genetics, Diabetes Mellitus, Experimental physiopathology, Diabetic Nephropathies genetics, Diabetic Nephropathies physiopathology, Hyperglycemia genetics, Hyperglycemia physiopathology, Kidney physiopathology, Lactoylglutathione Lyase genetics, Mice, Mice, Knockout, Reactive Oxygen Species metabolism, Diabetes Mellitus, Experimental metabolism, Diabetic Nephropathies metabolism, Hyperglycemia metabolism, Kidney metabolism, Lactoylglutathione Lyase metabolism
- Abstract
Differences in susceptibility to diabetic nephropathy (DN) between mouse strains with identical levels of hyperglycemia correlate with renal levels of oxidative stress, shown previously to play a central role in the pathogenesis of DN. Susceptibility to DN appears to be genetically determined, but the critical genes have not yet been identified. Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived α-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. In this study, we show that in nondiabetic mice, knockdown of Glo1 increases to diabetic levels both MG modification of glomerular proteins and oxidative stress, causing alterations in kidney morphology indistinguishable from those caused by diabetes. We also show that in diabetic mice, Glo1 overexpression completely prevents diabetes-induced increases in MG modification of glomerular proteins, increased oxidative stress, and the development of diabetic kidney pathology, despite unchanged levels of diabetic hyperglycemia. Together, these data indicate that Glo1 activity regulates the sensitivity of the kidney to hyperglycemic-induced renal pathology and that alterations in the rate of MG detoxification are sufficient to determine the glycemic set point at which DN occurs.
- Published
- 2014
- Full Text
- View/download PDF
32. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
- Author
-
Menni C, Fauman E, Erte I, Perry JR, Kastenmüller G, Shin SY, Petersen AK, Hyde C, Psatha M, Ward KJ, Yuan W, Milburn M, Palmer CN, Frayling TM, Trimmer J, Bell JT, Gieger C, Mohney RP, Brosnan MJ, Suhre K, Soranzo N, and Spector TD
- Subjects
- Aged, Blood Glucose genetics, Diabetes Mellitus, Type 2 genetics, Diseases in Twins blood, Diseases in Twins genetics, Fasting, Female, Genome-Wide Association Study, Glucose Tolerance Test, Humans, Hyperglycemia genetics, Male, Metabolomics, Middle Aged, Prediabetic State genetics, Biomarkers blood, Blood Glucose metabolism, Diabetes Mellitus, Type 2 blood, Hyperglycemia blood, Prediabetic State blood
- Abstract
Using a nontargeted metabolomics approach of 447 fasting plasma metabolites, we searched for novel molecular markers that arise before and after hyperglycemia in a large population-based cohort of 2,204 females (115 type 2 diabetic [T2D] case subjects, 192 individuals with impaired fasting glucose [IFG], and 1,897 control subjects) from TwinsUK. Forty-two metabolites from three major fuel sources (carbohydrates, lipids, and proteins) were found to significantly correlate with T2D after adjusting for multiple testing; of these, 22 were previously reported as associated with T2D or insulin resistance. Fourteen metabolites were found to be associated with IFG. Among the metabolites identified, the branched-chain keto-acid metabolite 3-methyl-2-oxovalerate was the strongest predictive biomarker for IFG after glucose (odds ratio [OR] 1.65 [95% CI 1.39-1.95], P = 8.46 × 10(-9)) and was moderately heritable (h(2) = 0.20). The association was replicated in an independent population (n = 720, OR 1.68 [ 1.34-2.11], P = 6.52 × 10(-6)) and validated in 189 twins with urine metabolomics taken at the same time as plasma (OR 1.87 [1.27-2.75], P = 1 × 10(-3)). Results confirm an important role for catabolism of branched-chain amino acids in T2D and IFG. In conclusion, this T2D-IFG biomarker study has surveyed the broadest panel of nontargeted metabolites to date, revealing both novel and known associated metabolites and providing potential novel targets for clinical prediction and a deeper understanding of causal mechanisms.
- Published
- 2013
- Full Text
- View/download PDF
33. In vivo adeno-associated viral vector-mediated genetic engineering of white and brown adipose tissue in adult mice.
- Author
-
Jimenez V, Muñoz S, Casana E, Mallol C, Elias I, Jambrina C, Ribera A, Ferre T, Franckhauser S, and Bosch F
- Subjects
- Animals, Dependovirus, Diabetes Mellitus, Type 2 genetics, Energy Metabolism genetics, Genetic Engineering, Hyperglycemia genetics, Male, Mice, Mice, Inbred ICR, Mice, Inbred NOD, Mice, Obese, Mitochondria genetics, Adipose Tissue, Brown metabolism, Adipose Tissue, White metabolism, Diabetes Mellitus, Type 2 metabolism, Hyperglycemia metabolism, Mitochondria metabolism
- Abstract
Adipose tissue is pivotal in the regulation of energy homeostasis through the balance of energy storage and expenditure and as an endocrine organ. An inadequate mass and/or alterations in the metabolic and endocrine functions of adipose tissue underlie the development of obesity, insulin resistance, and type 2 diabetes. To fully understand the metabolic and molecular mechanism(s) involved in adipose dysfunction, in vivo genetic modification of adipocytes holds great potential. Here, we demonstrate that adeno-associated viral (AAV) vectors, especially serotypes 8 and 9, mediated efficient transduction of white (WAT) and brown adipose tissue (BAT) in adult lean and obese diabetic mice. The use of short versions of the adipocyte protein 2 or uncoupling protein-1 promoters or micro-RNA target sequences enabled highly specific, long-term AAV-mediated transgene expression in white or brown adipocytes. As proof of concept, delivery of AAV vectors encoding for hexokinase or vascular endothelial growth factor to WAT or BAT resulted in increased glucose uptake or increased vessel density in targeted depots. This method of gene transfer also enabled the secretion of stable high levels of the alkaline phosphatase marker protein into the bloodstream by transduced WAT. Therefore, AAV-mediated genetic engineering of adipose tissue represents a useful tool for the study of adipose pathophysiology and, likely, for the future development of new therapeutic strategies for obesity and diabetes.
- Published
- 2013
- Full Text
- View/download PDF
34. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men.
- Author
-
Mahendran Y, Vangipurapu J, Cederberg H, Stancáková A, Pihlajamäki J, Soininen P, Kangas AJ, Paananen J, Civelek M, Saleem NK, Pajukanta P, Lusis AJ, Bonnycastle LL, Morken MA, Collins FS, Mohlke KL, Boehnke M, Ala-Korpela M, Kuusisto J, and Laakso M
- Subjects
- 3-Hydroxybutyric Acid blood, Acetoacetates blood, Area Under Curve, Biomarkers blood, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 genetics, Fasting, Finland epidemiology, Genome-Wide Association Study, Glucose Tolerance Test, Humans, Hyperglycemia epidemiology, Hyperglycemia genetics, Male, Metabolic Syndrome blood, Metabolic Syndrome epidemiology, Middle Aged, Predictive Value of Tests, Risk Factors, White People genetics, Blood Glucose metabolism, Diabetes Mellitus, Type 2 blood, Hyperglycemia blood, Ketone Bodies blood, Polymorphism, Single Nucleotide
- Abstract
We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed type 2 diabetes. Increasing fasting and 2-h plasma glucose levels were associated with elevated levels of acetoacetate (AcAc) and β-hydroxybutyrate (BHB). AcAc and BHB predicted an increase in the glucose area under the curve in an oral glucose tolerance test, and AcAc predicted the conversion to type 2 diabetes in a 5-year follow-up of the METSIM cohort. Impaired insulin secretion, but not insulin resistance, explained these findings. Of the 62 single nucleotide polymorphisms associated with the risk of type 2 diabetes or hyperglycemia, the glucose-increasing C allele of GCKR significantly associated with elevated levels of fasting BHB levels. Adipose tissue mRNA expression levels of genes involved in ketolysis were significantly associated with insulin sensitivity (Matsuda index). In conclusion, high levels of KBs predicted subsequent worsening of hyperglycemia, and a common variant of GCKR was significantly associated with BHB levels.
- Published
- 2013
- Full Text
- View/download PDF
35. Hyperglycemia mediates a shift from cap-dependent to cap-independent translation via a 4E-BP1-dependent mechanism.
- Author
-
Dennis MD, Shenberger JS, Stanley BA, Kimball SR, and Jefferson LS
- Subjects
- Adaptor Proteins, Signal Transducing, Animals, Blood Glucose, Carrier Proteins metabolism, Cell Cycle Proteins, Cells, Cultured, Diabetes Mellitus, Experimental metabolism, Eukaryotic Initiation Factors, Fibroblasts metabolism, Hyperglycemia metabolism, Mass Spectrometry, Mice, Mice, Knockout, Phosphoproteins metabolism, Up-Regulation, Carrier Proteins genetics, Diabetes Mellitus, Experimental genetics, Hyperglycemia genetics, Liver metabolism, Phosphoproteins genetics, Protein Biosynthesis physiology
- Abstract
Diabetes and its associated hyperglycemia induce multiple changes in liver function, yet we know little about the role played by translational control of gene expression in mediating the responses to these conditions. Here, we evaluate the hypothesis that hyperglycemia-induced O-GlcNAcylation of the translational regulatory protein 4E-BP1 alters hepatic gene expression through a process involving the selection of mRNA for translation. In both streptozotocin (STZ)-treated mice and cells in culture exposed to hyperglycemic conditions, expression of 4E-BP1 and its interaction with the mRNA cap-binding protein eIF4E were enhanced in conjunction with downregulation of cap-dependent and concomitant upregulation of cap-independent mRNA translation, as assessed by a bicistronic luciferase reporter assay. Phlorizin treatment of STZ-treated mice lowered blood glucose concentrations and reduced activity of the cap-independent reporter. Notably, the glucose-induced shift from cap-dependent to cap-independent mRNA translation did not occur in cells lacking 4E-BP1. The extensive nature of this shift in translational control of gene expression was revealed using pulsed stable isotope labeling by amino acids in cell culture to identify proteins that undergo altered rates of synthesis in response to hyperglycemia. Taken together, these data provide evidence for a novel mechanism whereby O-GlcNAcylation of 4E-BP1 mediates translational control of hepatic gene expression.
- Published
- 2013
- Full Text
- View/download PDF
36. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
- Author
-
Spégel P, Ekholm E, Tuomi T, Groop L, Mulder H, and Filipsson K
- Subjects
- Adult, Diabetes Mellitus, Type 2 blood, Fatty Acids, Nonesterified blood, Female, Hepatocyte Nuclear Factor 1-alpha genetics, Hepatocyte Nuclear Factor 4 genetics, Humans, Hyperglycemia genetics, Male, Middle Aged, Triglycerides blood, Diabetes Mellitus, Type 2 genetics, Glucokinase genetics, Metabolome genetics, Mutation
- Abstract
Mutations in the gene encoding glucokinase (GCK) cause a mild hereditary form of diabetes termed maturity-onset diabetes of the young (MODY)2 or GCK-MODY. The disease does not progress over time, and diabetes complications rarely develop. It has therefore been suggested that GCK-MODY represents a metabolically compensated condition, but experimental support for this notion is lacking. Here, we profiled metabolites in serum from patients with MODY1 (HNF4A), MODY2 (GCK), MODY3 (HNF1A), and type 2 diabetes and from healthy individuals to characterize metabolic perturbations caused by specific mutations. Analysis of four GCK-MODY patients revealed a metabolite pattern similar to that of healthy individuals, while other forms of diabetes differed markedly in their metabolite profiles. Furthermore, despite elevated glucose concentrations, carriers of GCK mutations showed lower levels of free fatty acids and triglycerides than healthy control subjects. The metabolite profiling was confirmed by enzymatic assays and replicated in a cohort of 11 GCK-MODY patients. Elevated levels of fatty acids are known to associate with β-cell dysfunction, insulin resistance, and increased incidence of late complications. Our results show that GCK-MODY represents a metabolically normal condition, which may contribute to the lack of late complications and the nonprogressive nature of the disease.
- Published
- 2013
- Full Text
- View/download PDF
37. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men.
- Author
-
Stancáková A, Civelek M, Saleem NK, Soininen P, Kangas AJ, Cederberg H, Paananen J, Pihlajamäki J, Bonnycastle LL, Morken MA, Boehnke M, Pajukanta P, Lusis AJ, Collins FS, Kuusisto J, Ala-Korpela M, and Laakso M
- Subjects
- Adipose Tissue metabolism, Aged, Blood Glucose analysis, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 genetics, Finland, Gene Expression Regulation genetics, Genetic Predisposition to Disease, Humans, Insulin Resistance genetics, Male, Middle Aged, Adaptor Proteins, Signal Transducing genetics, Amino Acids blood, Hyperglycemia genetics
- Abstract
We investigated the association of glycemia and 43 genetic risk variants for hyperglycemia/type 2 diabetes with amino acid levels in the population-based Metabolic Syndrome in Men (METSIM) Study, including 9,369 nondiabetic or newly diagnosed type 2 diabetic Finnish men. Plasma levels of eight amino acids were measured with proton nuclear magnetic resonance spectroscopy. Increasing fasting and 2-h plasma glucose levels were associated with increasing levels of several amino acids and decreasing levels of histidine and glutamine. Alanine, leucine, isoleucine, tyrosine, and glutamine predicted incident type 2 diabetes in a 4.7-year follow-up of the METSIM Study, and their effects were largely mediated by insulin resistance (except for glutamine). We also found significant correlations between insulin sensitivity (Matsuda insulin sensitivity index) and mRNA expression of genes regulating amino acid degradation in 200 subcutaneous adipose tissue samples. Only 1 of 43 risk single nucleotide polymorphisms for type 2 diabetes or hyperglycemia, the glucose-increasing major C allele of rs780094 of GCKR, was significantly associated with decreased levels of alanine and isoleucine and elevated levels of glutamine. In conclusion, the levels of branched-chain, aromatic amino acids and alanine increased and the levels of glutamine and histidine decreased with increasing glycemia, reflecting, at least in part, insulin resistance. Only one single nucleotide polymorphism regulating hyperglycemia was significantly associated with amino acid levels.
- Published
- 2012
- Full Text
- View/download PDF
38. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice.
- Author
-
Klymiuk N, van Buerck L, Bähr A, Offers M, Kessler B, Wuensch A, Kurome M, Thormann M, Lochner K, Nagashima H, Herbach N, Wanke R, Seissler J, and Wolf E
- Subjects
- Animals, Animals, Genetically Modified, Cell Differentiation immunology, Diabetes Mellitus, Type 1 genetics, Diabetes Mellitus, Type 1 immunology, Graft Rejection immunology, Hyperglycemia genetics, Hyperglycemia immunology, Hyperglycemia surgery, Insulin genetics, Mice, Promoter Regions, Genetic, Swine, Diabetes Mellitus, Type 1 surgery, Graft Rejection prevention & control, Islets of Langerhans Transplantation immunology, Transplantation, Heterologous immunology
- Abstract
Islet transplantation is a potential treatment for type 1 diabetes, but the shortage of donor organs limits its routine application. As potential donor animals, we generated transgenic pigs expressing LEA29Y, a high-affinity variant of the T-cell costimulation inhibitor CTLA-4Ig, under the control of the porcine insulin gene promoter. Neonatal islet cell clusters (ICCs) from INSLEA29Y transgenic (LEA-tg) pigs and wild-type controls were transplanted into streptozotocin-induced hyperglycemic NOD-scid IL2Rγ(null) mice. Cloned LEA-tg pigs are healthy and exhibit a strong β-cell-specific transgene expression. LEA-tg ICCs displayed the same potential to normalize glucose homeostasis as wild-type ICCs after transplantation. After adoptive transfer of human peripheral blood mononuclear cells, transplanted LEA-tg ICCs were completely protected from rejection, whereas reoccurrence of hyperglycemia was observed in 80% of mice transplanted with wild-type ICCs. In the current study, we provide the first proof-of-principle report on transgenic pigs with β-cell-specific expression of LEA29Y and their successful application as donors in a xenotransplantation model. This approach may represent a major step toward the development of a novel strategy for pig-to-human islet transplantation without side effects of systemic immunosuppression.
- Published
- 2012
- Full Text
- View/download PDF
39. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression.
- Author
-
Olsen AS, Sarras MP Jr, Leontovich A, and Intine RV
- Subjects
- Animals, CpG Islands, Diabetes Mellitus, Experimental physiopathology, Gene Expression, Glycation End Products, Advanced metabolism, Hyperglycemia genetics, Regeneration, Streptozocin, Transcription Factor RelA metabolism, Wound Healing, Zebrafish, DNA Methylation, Diabetes Complications genetics, Diabetes Mellitus, Experimental genetics
- Abstract
Metabolic memory (MM) is the phenomenon whereby diabetes complications persist and progress after glycemic recovery is achieved. Here, we present data showing that MM is heritable and that the transmission correlates with hyperglycemia-induced DNA hypomethylation and aberrant gene expression. Streptozocin was used to induce hyperglycemia in adult zebrafish, and then, following streptozocin withdrawal, a recovery phase was allowed to reestablish a euglycemic state. Blood glucose and serum insulin returned to physiological levels during the first 2 weeks of the recovery phase as a result of pancreatic β-cell regeneration. In contrast, caudal fin regeneration and skin wound healing remained impaired to the same extent as in diabetic fish, and this impairment was transmissible to daughter cell tissue. Daughter tissue that was never exposed to hyperglycemia, but was derived from tissue that was, did not accumulate AGEs or exhibit increased levels of oxidative stress. However, CpG island methylation and genome-wide microarray expression analyses revealed the persistence of hyperglycemia-induced global DNA hypomethylation that correlated with aberrant gene expression for a subset of loci in this daughter tissue. Collectively, the data presented here implicate the epigenetic mechanism of DNA methylation as a potential contributor to the MM phenomenon.
- Published
- 2012
- Full Text
- View/download PDF
40. Genetic ablation of cGMP-dependent protein kinase type I causes liver inflammation and fasting hyperglycemia.
- Author
-
Lutz SZ, Hennige AM, Feil S, Peter A, Gerling A, Machann J, Kröber SM, Rath M, Schürmann A, Weigert C, Häring HU, and Feil R
- Subjects
- Animals, Blotting, Western, Body Weight genetics, Cyclic GMP-Dependent Protein Kinase Type I, Cyclic GMP-Dependent Protein Kinases genetics, Eating genetics, Eating physiology, Energy Metabolism genetics, Fasting metabolism, Hyperglycemia genetics, Hyperglycemia metabolism, Immunohistochemistry, Inflammation immunology, Inflammation metabolism, Insulin pharmacology, Liver metabolism, Male, Mice, Mice, Knockout, Motor Activity genetics, Muscle, Skeletal metabolism, Phosphorylation genetics, Receptor, Insulin genetics, Receptor, Insulin metabolism, Signal Transduction drug effects, Cyclic GMP-Dependent Protein Kinases physiology, Fasting blood, Hyperglycemia enzymology, Inflammation genetics, Liver immunology
- Abstract
Objective: The nitric oxide/cGMP/cGMP-dependent protein kinase type I (cGKI) signaling pathway regulates cell functions that play a pivotal role in the pathogenesis of type 2 diabetes. However, the impact of a dysfunction of this pathway for glucose metabolism in vivo is unknown., Research Design and Methods: The expression of cGKI in tissues relevant to insulin action was analyzed by immunohistochemistry. The metabolic consequences of a genetic deletion of cGKI were studied in mice that express cGKI selectively in smooth muscle but not in other cell types (cGKI-SM mice)., Results: In wild-type mice, cGKI protein was detected in hepatic stellate cells, but not in hepatocytes, skeletal muscle, fat cells, or pancreatic β-cells. Compared with control animals, cGKI-SM mice had higher energy expenditure in the light phase associated with lower body weight and fat mass and increased insulin sensitivity. Mutant mice also showed higher fasting glucose levels, whereas insulin levels and intraperitoneal glucose tolerance test results were similar to those in control animals. Interleukin (IL)-6 signaling was strongly activated in the liver of cGKI-SM mice as demonstrated by increased levels of IL-6, phospho-signal transducer and activator of transcription 3 (Tyr 705), suppressor of cytokine signaling-3, and serum amyloid A2. Insulin-stimulated tyrosine phosphorylation of the insulin receptor in the liver was impaired in cGKI-SM mice. The fraction of Mac-2-positive macrophages in the liver was significantly higher in cGKI-SM mice than in control mice. In contrast with cGKI-SM mice, conditional knockout mice lacking cGKI only in the nervous system were normal with respect to body weight, energy expenditure, fasting glucose, IL-6, and insulin action in the liver., Conclusions: Genetic deletion of cGKI in non-neuronal cells results in a complex metabolic phenotype, including liver inflammation and fasting hyperglycemia. Loss of cGKI in hepatic stellate cells may affect liver metabolism via a paracrine mechanism that involves enhanced macrophage infiltration and IL-6 signaling.
- Published
- 2011
- Full Text
- View/download PDF
41. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.
- Author
-
Stančáková A, Paananen J, Soininen P, Kangas AJ, Bonnycastle LL, Morken MA, Collins FS, Jackson AU, Boehnke ML, Kuusisto J, Ala-Korpela M, and Laakso M
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Cholesterol, VLDL blood, Delta-5 Fatty Acid Desaturase, Diabetes Mellitus, Type 2 blood, Fatty Acid Desaturases blood, Genotype, Humans, Hyperglycemia blood, Lipoproteins, HDL blood, Lipoproteins, IDL blood, Lipoproteins, LDL blood, Lipoproteins, VLDL blood, Magnetic Resonance Spectroscopy, Male, Middle Aged, Polymorphism, Single Nucleotide genetics, Receptor, Notch2 blood, White People, Diabetes Mellitus, Type 2 genetics, Hyperglycemia genetics
- Abstract
Objective: We investigated the effects of 34 genetic risk variants for hyperglycemia/type 2 diabetes on lipoprotein subclasses and particle composition in a large population-based cohort., Research Design and Methods: The study included 6,580 nondiabetic Finnish men from the population-based Metabolic Syndrome in Men (METSIM) study (aged 57 ± 7 years; BMI 26.8 ± 3.7 kg/m(2)). Genotyping of 34 single nucleotide polymorphism (SNPs) for hyperglycemia/type 2 diabetes was performed. Proton nuclear magnetic resonance spectroscopy was used to measure particle concentrations of 14 lipoprotein subclasses and their composition in native serum samples., Results: The glucose-increasing allele of rs780094 in GCKR was significantly associated with low concentrations of VLDL particles (independently of their size) and small LDL and was nominally associated with low concentrations of intermediate-density lipoprotein, all LDL subclasses, and high concentrations of very large and large HDL particles. The glucose-increasing allele of rs174550 in FADS1 was significantly associated with high concentrations of very large and large HDL particles and nominally associated with low concentrations of all VLDL particles. SNPs rs10923931 in NOTCH2 and rs757210 in HNF1B genes showed nominal or significant associations with several lipoprotein traits. The genetic risk score of 34 SNPs was not associated with any of the lipoprotein subclasses., Conclusions: Four of the 34 risk loci for type 2 diabetes or hyperglycemia (GCKR, FADS1, NOTCH2, and HNF1B) were significantly associated with lipoprotein traits. A GCKR variant predominantly affected the concentration of VLDL, and the FADS1 variant affected very large and large HDL particles. Only a limited number of risk loci for hyperglycemia/type 2 diabetes significantly affect lipoprotein metabolism.
- Published
- 2011
- Full Text
- View/download PDF
42. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition.
- Author
-
Bellenger J, Bellenger S, Bataille A, Massey KA, Nicolaou A, Rialland M, Tessier C, Kang JX, and Narce M
- Subjects
- Animals, Blood Glucose metabolism, Blotting, Western, Caenorhabditis elegans Proteins genetics, Diabetes Mellitus, Experimental genetics, Fatty Acid Desaturases genetics, Female, Hyperglycemia genetics, Hyperglycemia metabolism, Hyperglycemia prevention & control, Immunohistochemistry, Insulin blood, Lipids blood, Male, Mice, Mice, Transgenic, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction genetics, Signal Transduction physiology, Transcription Factor RelA genetics, Transcription Factor RelA metabolism, Caenorhabditis elegans Proteins metabolism, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Experimental prevention & control, Fatty Acid Desaturases metabolism, Fatty Acids, Omega-3 metabolism
- Abstract
Objective: Because of confounding factors, the effects of dietary n-3 polyunsaturated fatty acids (PUFA) on type 1 diabetes remain to be clarified. We therefore evaluated whether fat-1 transgenic mice, a well-controlled experimental model endogenously synthesizing n-3 PUFA, were protected against streptozotocin (STZ)-induced diabetes. We then aimed to elucidate the in vivo response at the pancreatic level., Research Design and Methods: β-Cell destruction was produced by multiple low-doses STZ (MLD-STZ). Blood glucose level, plasma insulin level, and plasma lipid analysis were then performed. Pancreatic mRNA expression of cytokines, the monocyte chemoattractant protein, and GLUT2 were evaluated as well as pancreas nuclear factor (NF)-κB p65 and inhibitor of κB (IκB) protein expression. Insulin and cleaved caspase-3 immunostaining and lipidomic analysis were performed in the pancreas., Results: STZ-induced fat-1 mice did not develop hyperglycemia compared with wild-type mice, and β-cell destruction was prevented as evidenced by lack of histological pancreatic damage or reduced insulin level. The prevention of β-cell destruction was associated with no proinflammatory cytokine induction (tumor necrosis factor-α, interleukin-1β, inducible nitric oxide synthase) in the pancreas, a decreased NF-κB, and increased IκB pancreatic protein expression. In the fat-1-treated mice, proinflammatory arachidonic-derived mediators as prostaglandin E₂ and 12-hydroxyeicosatetraenoic acid were decreased and the anti-inflammatory lipoxin A₄ was detected. Moreover, the 18-hydroxyeicosapentaenoic acid, precursor of the anti-inflammatory resolvin E1, was highly increased., Conclusions: Collectively, these findings indicate that fat-1 mice were protected against MLD-STZ-induced diabetes and pointed out for the first time in vivo the beneficial effects of n-3 PUFA at the pancreatic level, on each step of the development of the pathology-inflammation, β-cell damage-through cytokine response and lipid mediator production.
- Published
- 2011
- Full Text
- View/download PDF
43. SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function.
- Author
-
Jurczak MJ, Lee HY, Birkenfeld AL, Jornayvaz FR, Frederick DW, Pongratz RL, Zhao X, Moeckel GW, Samuel VT, Whaley JM, Shulman GI, and Kibbey RG
- Subjects
- Analysis of Variance, Animals, Apoptosis genetics, Dietary Fats metabolism, Hyperglycemia genetics, Hyperglycemia metabolism, Hyperglycemia physiopathology, Insulin blood, Insulin Resistance, Islets of Langerhans metabolism, Islets of Langerhans physiopathology, Kidney metabolism, Mice, Mice, Knockout, Obesity genetics, Obesity physiopathology, Sodium-Glucose Transporter 2 genetics, Glucose metabolism, Homeostasis genetics, Insulin-Secreting Cells metabolism, Obesity metabolism, Sodium-Glucose Transporter 2 metabolism
- Abstract
Objective: Inhibition of the Na(+)-glucose cotransporter type 2 (SGLT2) is currently being pursued as an insulin-independent treatment for diabetes; however, the behavioral and metabolic consequences of SGLT2 deletion are unknown. Here, we used a SGLT2 knockout mouse to investigate the effect of increased renal glucose excretion on glucose homeostasis, insulin sensitivity, and pancreatic β-cell function., Research Design and Methods: SGLT2 knockout mice were fed regular chow or a high-fat diet (HFD) for 4 weeks, or backcrossed onto the db/db background. The analysis used metabolic cages, glucose tolerance tests, euglycemic and hyperglycemic clamps, as well as isolated islet and perifusion studies., Results: SGLT2 deletion resulted in a threefold increase in urine output and a 500-fold increase in glucosuria, as well as compensatory increases in feeding, drinking, and activity. SGLT2 knockout mice were protected from HFD-induced hyperglycemia and glucose intolerance and had reduced plasma insulin concentrations compared with controls. On the db/db background, SGLT2 deletion prevented fasting hyperglycemia, and plasma insulin levels were also dramatically improved. Strikingly, prevention of hyperglycemia by SGLT2 knockout in db/db mice preserved pancreatic β-cell function in vivo, which was associated with a 60% increase in β-cell mass and reduced incidence of β-cell death., Conclusions: Prevention of renal glucose reabsorption by SGLT2 deletion reduced HFD- and obesity-associated hyperglycemia, improved glucose intolerance, and increased glucose-stimulated insulin secretion in vivo. Taken together, these data support SGLT2 inhibition as a viable insulin-independent treatment of type 2 diabetes.
- Published
- 2011
- Full Text
- View/download PDF
44. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size.
- Author
-
Gu Y, Lindner J, Kumar A, Yuan W, and Magnuson MA
- Subjects
- Alleles, Analysis of Variance, Animals, Apoptosis physiology, Blotting, Western, Carrier Proteins genetics, Fluorescent Antibody Technique, Genotype, Glucose metabolism, Glucose Intolerance genetics, Glucose Intolerance metabolism, Hyperglycemia genetics, Hyperglycemia metabolism, Mice, Mice, Knockout, PTEN Phosphohydrolase genetics, PTEN Phosphohydrolase metabolism, Phosphorylation physiology, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Rapamycin-Insensitive Companion of mTOR Protein, Reverse Transcriptase Polymerase Chain Reaction, Carrier Proteins metabolism, Cell Proliferation, Cell Size, Insulin-Secreting Cells cytology, Insulin-Secreting Cells metabolism, Signal Transduction physiology
- Abstract
Objective: We examined the role of Rictor/mammalian target of rapamycin complex 2 (mTORC2), a key component of the phosphotidylinositol-3-kinase (PI3K)/mTORC2/AKT signaling pathway, in regulating both β-cell mass and function., Research Design and Methods: Mice with β-cell-specific deletions of Rictor or Pten were studied to determine the effects of deleting either or both genes on β-cell mass and glucose homeostasis., Results: Rictor null mice exhibited mild hyperglycemia and glucose intolerance caused by a reduction in β-cell mass, β-cell proliferation, pancreatic insulin content, and glucose-stimulated insulin secretion. Islets from these mice exhibited decreased AKT-S473 phosphorylation and increased abundance of FoxO1 and p27 proteins. Conversely, Pten null (βPtenKO) mice exhibited an increase in β-cell mass caused by increased cellular proliferation and size. Although β-cell mass was normal in mice lacking both Rictor and Pten (βDKO), their β-cells were larger than those in the βPtenKO mice. Even though the β-cell proliferation rate in the βDKO mice was lower than in the βPtenKO mice, there was a 12-fold increase the phosphorylation of AKT-T308., Conclusions: PI3K/AKT signaling through mTORC2/pAKT-S473 plays a key role in maintaining normal β-cell mass. The phosphorylation of AKT-S473, by negatively regulating that of AKT-T308, is essential for maintaining a balance between β-cell proliferation and cell size in response to proliferative stimuli.
- Published
- 2011
- Full Text
- View/download PDF
45. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue.
- Author
-
Koenen TB, Stienstra R, van Tits LJ, de Graaf J, Stalenhoef AF, Joosten LA, Tack CJ, and Netea MG
- Subjects
- Analysis of Variance, Animals, Blotting, Western, Glucose metabolism, Glucose pharmacology, Humans, Hyperglycemia metabolism, Interleukin-1beta metabolism, Male, Mice, Mice, Obese, Obesity genetics, RNA, Small Interfering, Reverse Transcriptase Polymerase Chain Reaction, Adipose Tissue metabolism, Carrier Proteins metabolism, Caspase 1 metabolism, Hyperglycemia genetics, Interleukin-1beta genetics, Obesity metabolism
- Abstract
Objective: Obesity is characterized by elevated levels of proinflammatory cytokines, including interleukin (IL)-1β, that contribute to the development of insulin resistance. In this study, we set out to investigate whether hyperglycemia drives IL-1β production and caspase-1 activation in murine and human adipose tissue, thus inducing insulin resistance., Research Design and Methods: ob/ob animals were used as a model to study obesity and hyperglycemia. Human adipose tissue fragments or adipocytes were cultured in medium containing normal or high glucose levels. Additionally, the role of thioredoxin interacting protein (TXNIP) in glucose-induced IL-1β production was assessed., Results: TXNIP and caspase-1 protein levels were more abundantly expressed in adipose tissue of hyperglycemic ob/ob animals as compared with wild-type mice. In human adipose tissue, high glucose resulted in a 10-fold upregulation of TXNIP gene expression levels (P < 0.01) and a 10% elevation of caspase-1 activity (P < 0.05), together with induction of IL-1β transcription (twofold, P < 0.01) and a significant increase in IL-1β secretion. TXNIP suppression in human adipocytes, either by a small interfering RNA approach or a peroxisome proliferator-activated receptor-γ agonist, counteracted the effects of high glucose on bioactive IL-1 production (P < 0.01) mainly through a decrease in transcription levels paralleled by reduced intracellular pro-IL-1β levels., Conclusions: High glucose activates caspase-1 in human and murine adipose tissue. Glucose-induced activation of TXNIP mediates IL-1β mRNA expression levels and intracellular pro-IL-1β accumulation in adipose tissue. The concerted actions lead to enhanced secretion of IL-1β in adipose tissue that may contribute to the development of insulin resistance.
- Published
- 2011
- Full Text
- View/download PDF
46. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study.
- Author
-
Renström F, Shungin D, Johansson I, Florez JC, Hallmans G, Hu FB, and Franks PW
- Subjects
- Blood Glucose metabolism, Blood Pressure, Body Mass Index, Chromosome Mapping, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 genetics, Fasting, Female, Follow-Up Studies, Gene Expression Profiling, Homeostasis, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Reference Values, Risk Assessment, Time Factors, Triglycerides blood, Genetic Predisposition to Disease, Glucose metabolism, Hyperglycemia genetics
- Abstract
Objective: To assess whether recently discovered genetic loci associated with hyperglycemia also predict long-term changes in glycemic traits., Research Design and Methods: Sixteen fasting glucose-raising loci were genotyped in middle-aged adults from the Gene x Lifestyle interactions And Complex traits Involved in Elevated disease Risk (GLACIER) Study, a population-based prospective cohort study from northern Sweden. Genotypes were tested for association with baseline fasting and 2-h postchallenge glycemia (N = 16,330), and for changes in these glycemic traits during a 10-year follow-up period (N = 4,059)., Results: Cross-sectional directionally consistent replication with fasting glucose concentrations was achieved for 12 of 16 variants; 10 variants were also associated with impaired fasting glucose (IFG) and 7 were independently associated with 2-h postchallenge glucose concentrations. In prospective analyses, the effect alleles at four loci (GCK rs4607517, ADRA2A rs10885122, DGKB-TMEM195 rs2191349, and G6PC2 rs560887) were nominally associated with worsening fasting glucose concentrations during 10-years of follow-up. MTNR1B rs10830963, which was predictive of elevated fasting glucose concentrations in cross-sectional analyses, was associated with a protective effect on postchallenge glucose concentrations during follow-up; however, this was only when baseline fasting and 2-h glucoses were adjusted for. An additive effect of multiple risk alleles on glycemic traits was observed: a weighted genetic risk score (80th vs. 20th centiles) was associated with a 0.16 mmol/l (P = 2.4 × 10⁻⁶) greater elevation in fasting glucose and a 64% (95% CI: 33-201%) higher risk of developing IFG during 10 years of follow-up., Conclusions: Our findings imply that genetic profiling might facilitate the early detection of persons who are genetically susceptible to deteriorating glucose control; studies of incident type 2 diabetes and discrete cardiovascular end points will help establish whether the magnitude of these changes is clinically relevant.
- Published
- 2011
- Full Text
- View/download PDF
47. Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction.
- Author
-
Pendse AA, Johnson LA, Tsai YS, and Maeda N
- Subjects
- Adipose Tissue drug effects, Adipose Tissue physiopathology, Amino Acid Substitution, Animals, Blood Glucose metabolism, Cardiovascular Diseases genetics, Cardiovascular Diseases mortality, Cholesterol blood, Fatty Acids, Nonesterified blood, Female, Glucose metabolism, Humans, Insulin metabolism, Insulin pharmacology, Male, Mice, Mice, Inbred Strains, Pyruvates pharmacology, Sex Characteristics, Triglycerides blood, Adipose Tissue metabolism, Hyperglycemia genetics, Insulin Resistance genetics, Mutation, PPAR gamma genetics
- Abstract
Objective: The dominant-negative P467L mutation in peroxisome proliferator activated receptor-γ (PPARγ) was identified in insulin-resistant patients with hyperglycemia and lipodystrophy. In contrast, mice carrying the corresponding Pparg-P465L mutation have normal insulin sensitivity, with mild hyperinsulinemia. We hypothesized that murine Pparg-P465L mutation leads to covert insulin resistance, which is masked by hyperinsulinemia and increased pancreatic islet mass, to retain normal plasma glucose., Research Design and Methods: We introduced in Pparg(P465L/+) mice an Ins2-Akita mutation that causes improper protein folding and islet apoptosis to lower plasma insulin., Results: Unlike Ins2(Akita/+) littermates, male Pparg(P465L/+)Ins2(Akita/+) mice have drastically reduced life span with enhanced type 1 diabetes. Hyperglycemia in Ins2(Akita/+) females is mild. However, Pparg(P465L/+)Ins2(Akita/+) females have aggravated hyperglycemia, smaller islets, and reduced plasma insulin. In an insulin tolerance test, they showed smaller reduction in plasma glucose, indicating impaired insulin sensitivity. Although gluconeogenesis is enhanced in Pparg(P465L/+)Ins2(Akita/+) mice compared with Ins2(Akita/+), exogenous insulin equally suppressed gluconeogenesis in hepatocytes, suggesting that Pparg(P465L/+)Ins2(Akita/+) livers are insulin sensitive. Expression of genes regulating insulin sensitivity and glycogen and triglyceride contents suggest that skeletal muscles are equally insulin sensitive. In contrast, adipose tissue and isolated adipocytes from Pparg(P465L/+)Ins2(Akita/+) mice have impaired glucose uptake in response to exogenous insulin. Pparg(P465L/+)Ins2(Akita/+) mice have smaller fat depots composed of larger adipocytes, suggesting impaired lipid storage with subsequent hepatomegaly and hypertriglyceridemia., Conclusions: PPARg-P465L mutation worsens hyperglycemia in Ins2(Akita/+) mice primarily because of adipose-specific insulin resistance and altered storage function. This underscores the important interplay between insulin and PPARγ in adipose tissues in diabetes.
- Published
- 2010
- Full Text
- View/download PDF
48. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups.
- Author
-
Freathy RM, Hayes MG, Urbanek M, Lowe LP, Lee H, Ackerman C, Frayling TM, Cox NJ, Dunger DB, Dyer AR, Hattersley AT, Metzger BE, and Lowe WL Jr
- Subjects
- Birth Weight genetics, Female, Genotype, Germinal Center Kinases, Humans, Infant, Newborn, Polymorphism, Single Nucleotide, Pregnancy, Pregnancy Outcome, Transcription Factor 7-Like 2 Protein, White People genetics, Genetic Variation, Hyperglycemia complications, Hyperglycemia genetics, Pregnancy Complications genetics, Pregnancy in Diabetics genetics, Protein Serine-Threonine Kinases genetics, TCF Transcription Factors genetics
- Abstract
Objective: Common genetic variants in GCK and TCF7L2 are associated with higher fasting glucose and type 2 diabetes in nonpregnant populations. However, their associations with glucose levels from oral glucose tolerance tests (OGTTs) in pregnancy have not been assessed in a large sample. We hypothesized that these variants are associated with quantitative measures of glycemia in pregnancy., Research Design and Methods: We analyzed the associations between variants rs1799884 (GCK) and rs7903146 (TCF7L2) and OGTT outcomes at 24-32 weeks' gestation in 3,811 mothers of European (U.K. and Australia) and 1,706 mothers of Asian (Thailand) ancestry from the HAPO cohort. We also tested associations with offspring birth anthropometrics., Results: The maternal GCK variant was associated with higher fasting glucose in Europeans (P = 0.001) and Thais (P < 0.0001), 1-h glucose in Europeans (P = 0.001), and 2-h glucose in Thais (P = 0.005). It was also associated with higher European offspring birth weight, fat mass, and skinfold thicknesses (P < 0.05). The TCF7L2 variant was associated with all three maternal glucose outcomes (P = 0.03, P < 0.0001, and P < 0.0001 for fasting and 1-h and 2-h glucose, respectively) in the Europeans but not in the Thais (P > 0.05). In both populations, both variants were associated with higher odds of gestational diabetes mellitus according to the new International Association of Diabetes and Pregnancy Study Groups recommendations (P = 0.001-0.08)., Conclusions: Maternal GCK and TCF7L2 variants are associated with glucose levels known to carry an increased risk of adverse pregnancy outcome in women without overt diabetes. Further studies will be important to determine the variance in maternal glucose explained by all known genetic variants.
- Published
- 2010
- Full Text
- View/download PDF
49. Ablation of 4E-BP1/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture.
- Author
-
Schrufer TL, Antonetti DA, Sonenberg N, Kimball SR, Gardner TW, and Jefferson LS
- Subjects
- Adaptor Proteins, Signal Transducing, Adolescent, Animals, Cell Cycle Proteins, Child, Diabetic Retinopathy epidemiology, Eukaryotic Initiation Factor-4E genetics, Eukaryotic Initiation Factors genetics, Gene Deletion, Gene Expression Regulation, Humans, Hyperglycemia genetics, Intracellular Signaling Peptides and Proteins, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Genetic, RNA, Messenger genetics, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Carrier Proteins genetics, Diabetes Mellitus, Type 1 genetics, Phosphoproteins genetics, Vascular Endothelial Growth Factor A genetics
- Abstract
Objective: Vascular endothelial growth factor (VEGF) contributes to diabetic retinopathy, but control of its expression is not well understood. Here, we tested the hypothesis that hyperglycemia mediates induction of VEGF expression in a eukaryotic initiation factor 4E (eIF4E) binding protein (4E-BP) 1 and 2 dependent manner., Research Design and Methods: The retina was harvested from control and type 1 diabetic rats and mice and analyzed for VEGF mRNA and protein expression as well as biomarkers of translational control mechanisms. Similar analyses were performed in Müller cell cultures exposed to hyperglycemic conditions. The effect of 4E-BP1 and 4E-BP2 gene deletion on VEGF expression was examined in mice and in mouse embryo fibroblasts (MEFs)., Results: Whereas VEGF mRNA in the retina remained constant, VEGF expression was increased as early as 2 weeks after the onset of diabetes. Increases in expression of 4E-BP1 protein mirrored those of VEGF and expression of 4E-BP1 mRNA was unchanged. Similar results were observed after 10 h of exposure of cells in culture to hyperglycemic conditions. Importantly, the diabetes-induced increase in VEGF expression was not observed in mice deficient in 4E-BP1 and 4E-BP2, nor in MEFs lacking the two proteins., Conclusions: Hyperglycemia induces VEGF expression through cap-independent mRNA translation mediated by increased expression of 4E-BP1. Because the VEGF mRNA contains two internal ribosome entry sites, the increased expression is likely a consequence of ribosome loading at these sites. These findings provide new insights into potential targets for treatment of diabetic retinopathy.
- Published
- 2010
- Full Text
- View/download PDF
50. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
- Author
-
Takashima M, Ogawa W, Hayashi K, Inoue H, Kinoshita S, Okamoto Y, Sakaue H, Wataoka Y, Emi A, Senga Y, Matsuki Y, Watanabe E, Hiramatsu R, and Kasuga M
- Subjects
- Animals, Blood Glucose metabolism, Blotting, Western, Cells, Cultured, Diabetes Mellitus, Type 2 genetics, Gene Expression drug effects, Gluconeogenesis drug effects, Hepatocytes cytology, Hepatocytes drug effects, Hyperglycemia genetics, Hypoglycemic Agents metabolism, Hypoglycemic Agents pharmacology, Liver drug effects, Male, Metformin pharmacology, Mice, Mice, Transgenic, Rats, Reverse Transcriptase Polymerase Chain Reaction, Diabetes Mellitus, Type 2 metabolism, Gluconeogenesis genetics, Hepatocytes metabolism, Kruppel-Like Transcription Factors metabolism, Liver metabolism, Metformin metabolism
- Abstract
Objective: An increase in the rate of gluconeogenesis is largely responsible for the hyperglycemia in individuals with type 2 diabetes, with the antidiabetes action of metformin being thought to be achieved at least in part through suppression of gluconeogenesis., Research Design and Methods: We investigated whether the transcription factor KLF15 has a role in the regulation of gluconeogenesis and whether KLF15 participates in the antidiabetes effect of metformin., Results: Here we show that KLF15 regulates the expression of genes for gluconeogenic or amino acid-degrading enzymes in coordination with the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1alpha. Liver-specific ablation of KLF15 in diabetic mice resulted in downregulation of the expression of genes for gluconeogenic or amino acid catabolic enzymes and in amelioration of hyperglycemia. Exposure of cultured hepatocytes to metformin reduced the abundance of KLF15 through acceleration of its degradation and downregulation of its mRNA. Metformin suppressed the expression of genes for gluconeogenic or amino acid-degrading enzymes in cultured hepatocytes, and these effects of metformin were attenuated by restoration of KLF15 expression. Administration of metformin to mice inhibited both the expression of KLF15 and glucose production in the liver, the latter effect also being attenuated by restoration of hepatic KLF15 expression., Conclusions: KLF15 plays an important role in regulation of the expression of genes for gluconeogenic and amino acid-degrading enzymes and that the inhibitory effect of metformin on gluconeogenesis is mediated at least in part by downregulation of KLF15 and consequent attenuation of the expression of such genes.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.